10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

☑QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended December 29, 2017.

OR

☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number 1-6357

ESTERLINE TECHNOLOGIES CORPORATION

(Exact name of registrant as specified in its charter)

Delaware	13-2595091
(State or other jurisdiction	(I.R.S. Employer
of incorporation or organization)	Identification No.)

500 108th Avenue N.E., Bellevue, Washington 98004

(Address of principal executive offices)(Zip Code)

Registrant’s telephone number, including area code (425) 453-9400

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☐    No  ☑

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  ☑    No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☑	Accelerated filer	☐
Non-accelerated filer	☐(Do not check if a smaller reporting company)	Smaller reporting company	☐
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ☐    No  ☑

As of March 27, 2018, 29,426,691 shares of the issuer’s common stock were outstanding.

1

PART I – FINANCIAL INFORMATION

Item 1.Financial Statements

ESTERLINE TECHNOLOGIES CORPORATION

CONSOLIDATED BALANCE SHEET

As of December 29, 2017, and September 29, 2017

(In thousands, except share amounts)

	December 29,		September 29,
	2017		2017
	(Unaudited)
ASSETS
Current Assets
Cash and cash equivalents	$	354,872	$	307,826
Accounts receivable, net of allowances of $15,777 and $16,035		374,700		430,524
Inventories
Raw materials and purchased parts		200,441		194,034
Work in progress		182,469		178,191
Finished goods		113,657		105,744
		496,567		477,969
Income tax refundable		8,487		12,814
Prepaid expenses		22,762		19,239
Other current assets		14,345		13,836
Current assets of businesses held for sale		2,834		6,501
Total Current Assets		1,274,567		1,268,709
Property, Plant and Equipment		874,752		862,715
Accumulated depreciation		528,119		514,081
		346,633		348,634
Other Non-Current Assets
Goodwill		1,058,293		1,053,573
Intangibles, net		350,005		359,166
Deferred income tax benefits		51,327		56,793
Other assets		20,221		19,804
Non-current assets of businesses held for sale		14,010		13,334
Total Assets	$	3,115,056	$	3,120,013

2

ESTERLINE TECHNOLOGIES CORPORATION

CONSOLIDATED BALANCE SHEET

As of December 29, 2017, and September 29, 2017

(In thousands, except share amounts)

	December 29,			September 29,
	2017			2017
	(Unaudited)
LIABILITIES AND SHAREHOLDERS' EQUITY
Current Liabilities
Accounts payable	$	133,656		$	138,595
Accrued liabilities		217,251			230,007
Current maturities of long-term debt		17,429			17,424
U.S. and foreign income taxes		1,501			582
Current liabilities of businesses held for sale		2,117			7,184
Total Current Liabilities		371,954			393,792
Long-Term Liabilities
Credit facilities		70,000			50,000
Long-term debt, net of current maturities		712,287			709,424
Deferred income tax liabilities		42,507			43,978
Pension and post-retirement obligations		66,465			66,981
Long-term U.S. income taxes payable		38,640			-
Other liabilities		18,435			18,838
Non-current liabilities of businesses held for sale		3,072			1,724
Shareholders' Equity
Common stock, par value $.20 per share, authorized 60,000,000 shares,    issued 33,145,166 and 33,117,473 shares		6,629			6,623
Additional paid-in capital		743,274			738,329
Treasury stock at cost, repurchased 3,423,427 and 3,135,927 shares		(328,959	)		(308,514	)
Retained earnings		1,620,206			1,655,187
Accumulated other comprehensive loss		(260,421	)		(266,870	)
Total Esterline Shareholders' Equity		1,780,729			1,824,755
Noncontrolling interests		10,967			10,521
Total Shareholders' Equity		1,791,696			1,835,276
Total Liabilities and Shareholders' Equity	$	3,115,056		$	3,120,013

3

ESTERLINE TECHNOLOGIES CORPORATION

CONSOLIDATED STATEMENT OF OPERATIONS AND

COMPREHENSIVE INCOME (LOSS)

For the Three-Month Periods Ended December 29, 2017, and December 30, 2016

(Unaudited)

(In thousands, except per share amounts)

	Three Months Ended
	December 29,			December 30,
	2017			2016
Net Sales	$	482,045		$	458,416
Cost of Sales		333,709			315,504
		148,336			142,912
Expenses
Selling, general & administrative		98,886			95,110
Research, development and engineering		25,842			21,706
Insurance recovery		-			(2,600	)
License fee income		(3,025	)		-
Total Expenses		121,703			114,216
Operating Earnings from Continuing Operations		26,633			28,696
Interest Income		(298	)		(96	)
Interest Expense		7,604			7,888
Earnings from Continuing Operations Before Income Taxes		19,327			20,904
Income Tax Expense		53,789			(463	)
Earnings (Loss) from Continuing Operations Including Noncontrolling Interests		(34,462	)		21,367
Earnings Attributable to Noncontrolling Interests		(353	)		(239	)
Earnings (Loss) from Continuing Operations Attributable to Esterline, Net of Tax		(34,815	)		21,128
Loss from Discontinued Operations Attributable to Esterline, Net of Tax		(166	)		(5,336	)
Net Earnings (Loss) Attributable to Esterline	$	(34,981	)	$	15,792
Earnings (Loss) Per Share Attributable to Esterline - Basic:
Continuing operations	$	(1.16	)	$	0.71
Discontinued operations		(0.01	)		(0.18	)
Earnings (Loss) Per Share	$	(1.17	)	$	0.53
Earnings (Loss) Per Share Attributable to Esterline - Diluted:
Continuing operations	$	(1.16	)	$	0.71
Discontinued operations		(0.01	)		(0.18	)
Earnings (Loss) Per Share	$	(1.17	)	$	0.53
Net Earnings (Loss)	$	(34,981	)	$	15,792
Change in Fair Value of Derivative Financial Instruments		(560	)		(6,841	)
Income Tax Expense (Benefit)		(110	)		(1,909	)
		(450	)		(4,932	)
Change in Pension and Post-Retirement Obligations		842			2,533
Income Tax Expense (Benefit)		297			992
		545			1,541
Foreign Currency Translation Adjustment		6,354			(53,021	)
Comprehensive Income (Loss)	$	(28,532	)	$	(40,620	)

4

ESTERLINE TECHNOLOGIES CORPORATION

CONSOLIDATED STATEMENT OF CASH FLOWS

For the Three-Month Periods Ended December 29, 2017, and December 30, 2016

(Unaudited)

(In thousands)

	December 29,			December 30,
	2017			2016
Cash Flows Provided (Used) by Operating Activities
Net earnings (loss) including noncontrolling interests	$	(34,628	)	$	16,031
Adjustments to reconcile net earnings (loss) including noncontrolling interests to net cash    provided (used) by operating activities:
Depreciation and amortization		26,216		$	25,625
Deferred income taxes		4,456			(9,152	)
Share-based compensation		3,998			4,171
Loss on disposal of fixed assets		2,007			-
Gain (loss) on assets held for sale		(89	)		4,728
Working capital changes:
Accounts receivable		61,148			48,499
Inventories		(15,790	)		(16,739	)
Prepaid expenses		(3,427	)		(2,075	)
Other current assets		(590	)		(876	)
Accounts payable		(5,870	)		(9,096	)
Accrued liabilities		(21,652	)		(11,388	)
U.S. and foreign income taxes		5,241			(6,883	)
Long-term U.S. income taxes payable		38,640			-
Other liabilities		(649	)		1,361
Other, net		3,427			1,325
		62,438			45,531
Cash Flows Provided (Used) by Investing Activities
Purchase of capital assets		(13,402	)		(15,298	)
		(13,402	)		(15,298	)
Cash Flows Provided (Used) by Financing Activities
Proceeds provided by stock issuance under employee stock plans		1,171			10,729
Withholding taxes on restricted stock units vested		(227	)		(863	)
Shares repurchased		(20,445	)		-
Repayment of long-term credit facilities		(5,000	)		(10,000	)
Repayment of long-term debt		(3,553	)		(3,073	)
Proceeds from issuance of long-term credit facilities		25,000			5,000
		(3,054	)		1,793
Effect of Foreign Exchange Rates on Cash and Cash Equivalents		1,064			(12,522	)
Net Increase (Decrease) in Cash and Cash Equivalents		47,046			19,504
Cash and Cash Equivalents - Beginning of Year		307,826			258,520
Cash and Cash Equivalents - End of Period	$	354,872		$	278,024
Supplemental Cash Flow Information:
Cash paid for interest	$	10,478		$	10,745
Cash paid for taxes		6,179			13,775

5

ESTERLINE TECHNOLOGIES CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

For the Three-Month Periods Ended December 29, 2017, and December 30, 2016

Note 1 – Basis of Presentation

The consolidated balance sheet as of December 29, 2017, the consolidated statement of operations and comprehensive income (loss) for the three-month periods ended December 29, 2017, and December 30, 2016, and the consolidated statement of cash flows for the three-month periods ended December 29, 2017, and December 30, 2016, are unaudited but, in the opinion of management, all of the necessary adjustments, consisting of normal recurring accruals, have been made to present fairly the financial statements referred to above in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X.  Accordingly, the above statements do not include all of the footnotes required for complete financial statements.  The results of operations and cash flows for the interim periods presented are not necessarily indicative of results that can be expected for the full year.

The notes to the consolidated financial statements in the Company’s Annual Report on Form 10-K for the fiscal year ended September 29, 2017, provide a summary of significant accounting policies and additional financial information that should be read in conjunction with this Form 10-Q.

The timing of the Company’s revenues is impacted by the purchasing patterns of customers and, as a result, revenues are not generated evenly throughout the year.  Moreover, the Company’s first fiscal quarter, October through December, includes significant holiday periods in both Europe and North America, resulting in fewer business days.

Note 2 – Recent Accounting Pronouncements

In March 2017 the Financial Accounting Standards Board (FASB) issued new guidance on the presentation of the net periodic cost of postretirement benefit programs.  The new standard requires sponsors of defined benefit postretirement plans to present the non-service cost components of net periodic benefit cost separate from the service cost component on the income statement.  The new standard also requires that the non-service cost components of net periodic benefit cost no longer be capitalized within assets.  The Company is evaluating the effects the standard will have on the Company’s consolidated financial statements and related disclosures beyond the change in income statement presentation.  This new standard is effective for the Company in fiscal year 2019, with early adoption permitted.

In January 2017 the FASB issued new guidance regarding the goodwill impairment test.  The new guidance eliminates the Step 2 valuation test when evaluating goodwill for impairment.  The new guidance requires that an entity performs its annual or interim goodwill test by comparing the fair value of the reporting unit with its carrying amount.  An entity should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value.  The loss recognized should not exceed the total amount of goodwill allocated to that reporting unit.  The guidance is effective for the Company in fiscal year 2021, with early adoption permitted.  The standard was implemented in the first quarter of fiscal 2018.

In October 2016 the FASB issued new guidance regarding income taxes.  The new guidance will require the tax effects of intercompany transactions, other than sales of inventory, to be recognized currently, eliminating an exception under current Generally Accepted Accounting Principles (GAAP) in which the tax effects of intra-entity asset transfers are deferred until the transferred asset is sold to a third party or otherwise recovered through use.  The Company is evaluating the effect the updated standard will have on the Company’s consolidated financial statements and related disclosures.  The guidance will be effective for the company in fiscal year 2019, with early adoption permitted.

In August 2016 the FASB issued new guidance addressing how certain cash receipts and cash payments are presented and classified in the statement of cash flows.  The Company is evaluating the effect the updated standard will have on the Company’s consolidated financial statements and related disclosures.  The guidance will be effective for the Company in fiscal year 2019, with early adoption permitted.

In June 2016 the FASB issued a new standard on the measurement of credit losses, which will impact the Company’s measurement of trade receivables.  The new standard replaces the current incurred loss model with a forward-looking expected loss model that is likely to result in earlier recognition of losses.  The Company is evaluating the effect the updated standard will have on the Company’s consolidated financial statements and related disclosures.  The new standard is effective for the Company in 2021, with early adoption permitted, but not earlier than 2020.

In February 2016 the FASB issued a new lease accounting standard, which provides revised guidance on accounting for lease arrangements by both lessors and lessees.  The central requirement of the new standard is that lessees must recognize lease-related assets and liabilities for all leases with a term longer than 12 months.  The Company is evaluating the effect the standard will have on the Company’s consolidated financial statements and related disclosures.  The new standard is effective for the Company in fiscal year 2020, with early adoption permitted.

6

In July 2015, the FASB issued guidance which simplifies the subsequent measurement of inventory by requiring inventory to be measured at the lower of cost and net realizable value. Net realizable value is the estimated selling price of inventory in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation.  This new guidance was adopted in the first quarter of fiscal 2018, with no impact to the Company’s consolidated financial statements and related disclosures.

Revenue Recognition

In May 2014 the FASB issued a comprehensive new revenue recognition standard that effectively replaces all current guidance on the topic.  The guidance permits the use of either a retrospective or a cumulative effect transition method.

The Company has performed a review of the new guidance against the Company’s current accounting practices.  The Company has reviewed a representative sample of contracts and other agreements with customers and evaluated the provisions contained within these agreements compared with the amended guidance.

This amended guidance is expected to change the revenue recognition practices for a number of revenue streams across our businesses; the most significant will be for certain U.S. government contracts and certain other contracts that meet one or more of the mandatory criteria, which will move revenue recognition from a “point-in-time” basis to an “over-time” basis.  The on-going effect of recording revenue on an “over-time” basis is not expected to be materially different than under the historical guidance.

The amended guidance is also expected to change the recognition of certain development costs that are contractually guaranteed for reimbursement by our customers.  Contractually guaranteed reimbursements for development efforts are currently recognized as the development activities are performed.  Under the amended guidance, the contractually guaranteed reimbursement specific to the development effort will be deferred as a contract liability and recognized as revenue when future products are delivered to the customer in cases where the Company does not transfer all intellectual property rights related to the development effort to the customer or does not have an enforceable right to payment for performance completed to date.  The costs associated with development effort under an arrangement with contractually guaranteed reimbursement will also be deferred, up to the amount reimbursed, and recognized through cost of goods sold as products are delivered to the customer.  The on-going effect of deferring contractually guaranteed reimbursements and the related costs until products are delivered to the customer is not expected to be materially different than under the historical guidance.

The new standard also significantly enhances required disclosures regarding revenue and related assets and liabilities.  The Company is in the process of implementing changes to business processes, systems and internal controls required to adopt the new accounting standard.

The updated standard becomes effective for the Company in the first quarter of fiscal 2019, with early adoption permitted.  The Company expects to apply the standard using the cumulative effect transition basis, with a cumulative effect adjustment recognized at the beginning of fiscal year 2019.

Note 3 – Earnings Per Share and Shareholders’ Equity

Basic earnings per share is computed on the basis of the weighted average number of shares outstanding during the year.  Diluted earnings per share includes the dilutive effect of stock options, restricted stock units and share units related to the Company’s performance share plan to the extent that performance share plan objectives are met.  Common shares issuable from stock options excluded from the calculation of diluted earnings per share because they were anti-dilutive were 809,875 in the three-month period ending December 30, 2016.  Shares used for calculating earnings per share are disclosed in the following table:

In Thousands	Three Months Ended
	December 29,		December 30,
	2017		2016
Shares used for basic earnings per share		29,903		29,547
Shares used for diluted earnings per share		29,903		29,831

The authorized capital stock of the Company consists of 25,000 shares of preferred stock ($100 par value), 475,000 shares of serial preferred stock ($1.00 par value), each issuable in series, and 60,000,000 shares of common stock ($.20 par value).  As of December 29, 2017, and September 29, 2017, there were no shares of preferred stock or serial preferred stock outstanding.

On June 19, 2014, the Company’s Board of Directors approved a $200 million share repurchase program.  In March 2015, the Company’s Board of Directors approved an additional $200 million for the share repurchase program.  Under the program, the Company is authorized to repurchase up to $400 million of outstanding shares of common stock from time to time, depending on market conditions, share price and other factors.  Repurchases may be made in the open market or through private transactions, in accordance with SEC requirements.  The Company may enter into a Rule 10(b)5-1 plan designed to facilitate the repurchase of all or a

7

portion of the repurchase amount.  The program does not require the Company to acquire a specific number of shares.  Common stock repurchased can be reissued, and accordingly, the Company accounts for repurchased stock under the cost method of accounting.

During the three months ended December 29, 2017, the Company repurchased 287,500 shares under this program at an average price paid per share of $71.11, for an aggregate purchase price of $20.4 million.  There were no shares repurchased during the three months ended December 30, 2016.  Subsequent to December 29, 2017, we repurchased 313,900 shares under this program at an average price paid per share of $72.25, for an aggregate purchase price of $23.0 million through March 30, 2018.  Since the program began, the Company has repurchased 3,737,327 shares for an aggregate purchase price of $352.0 million, with $48.0 million in shares remaining available for repurchase in the future.

Changes in issued and outstanding common shares are summarized as follows:

	Three Months Ended			Year Ended
	December 29,			September 29,
	2017			2017
Shares Issued:
Balance, beginning of year		33,117,473			32,564,252
Shares issued under share-based compensation plans		27,693			553,221
Balance, end of current period		33,145,166			33,117,473
Treasury Stock:
Balance, beginning of year		(3,135,927	)		(3,135,927	)
Shares purchased		(287,500	)		-
Balance, end of current period		(3,423,427	)		(3,135,927	)
Shares outstanding, end of period		29,721,739			29,981,546

The components of Accumulated Other Comprehensive Income (Loss):

In Thousands	December 29,			September 29,
	2017			2017
Unrealized gain on derivative contracts	$	12,909		$	13,469
Tax effect		(3,782	)		(3,892	)
		9,127			9,577
Pension and post-retirement obligations		(80,940	)		(81,782	)
Tax effect		27,659			27,956
		(53,281	)		(53,826	)
Foreign currency translation adjustment		(216,267	)		(222,621	)
Accumulated other comprehensive income (loss)	$	(260,421	)	$	(266,870	)

8

Note 4 – Retirement Benefits

The Company’s pension plans principally include a U.S. pension plan maintained by Esterline and a non-U.S. plan maintained by CMC Electronics, Inc. (CMC).  The Company also sponsors a number of other non-U.S. defined benefit pension plans, primarily in Belgium, France and Germany.  Components of periodic pension cost consisted of the following:

In Thousands	Three Months Ended
	December 29,			December 30,
	2017			2016
Components of Net Periodic Cost
Service cost	$	3,374		$	3,357
Interest cost		4,106			3,721
Expected return on plan assets		(6,808	)		(6,265	)
Amortization of prior service cost		126			114
Amortization of actuarial (gain) loss		797			1,763
Net periodic cost (benefit)	$	1,595		$	2,690

The Company amortizes prior service cost and actuarial gains and losses from accumulated other comprehensive income to expense over the remaining service period.

Note 5 – Fair Value Measurements

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.  A fair value hierarchy has been established that prioritizes the inputs to valuation techniques used to measure fair value.  An asset’s or liability’s level within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement.  The hierarchy of fair value measurements is described below:

Level 1 – Valuations are based on quoted prices that the Company has the ability to obtain in actively traded markets for identical assets and liabilities.  Since valuations are based on quoted prices that are readily and regularly available in an active market or exchange traded market, a valuation of these instruments does not require a significant degree of judgment.

Level 2 – Valuations are based on quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market.

Level 3 – Valuations are based on model-based techniques for which some or all of the assumptions are not observable and therefore obtained from indirect market information that is significant to the overall fair value measurement and which require a significant degree of management judgment.

The following table sets forth the Company’s financial assets and liabilities that were measured at fair value on a recurring basis by level within the fair value hierarchy at December 29, 2017, and September 29, 2017.

In Thousands	Level 2
	December 29,		September 29,
	2017		2017
Assets:
Derivative contracts designated as hedging instruments	$	13,273	$	13,932
Derivative contracts not designated as hedging instruments		893		284
Embedded derivatives		681		746
Liabilities:
Derivative contracts designated as hedging instruments	$	364	$	464
Derivative contracts not designated as hedging instruments		1,445		2,440
Embedded derivatives		1,792		2,239

9

In Thousands	Level 3
	December 29,		September 29,
	2017		2017
Assets:
Estimated value of assets held for sale	$	16,844	$	19,835
Liabilities:
Estimated value of liabilities held for sale	$	5,189	$	8,908

The Company’s embedded derivatives are the result of entering into sales or purchase contracts that are denominated in a currency other than the Company’s functional currency or the supplier’s or customer’s functional currency.  The fair value is determined by calculating the difference between quoted exchange rates at the time the contract was entered into and the period-end exchange rate.  These contracts are categorized as Level 2 in the fair value hierarchy.

The Company’s derivative contracts consist of foreign currency exchange contracts and, from time to time, interest rate swap agreements.  These derivative contracts are over the counter, and their fair value is determined using modeling techniques that include market inputs such as interest rates, yield curves, and currency exchange rates.  These contracts are categorized as Level 2 in the fair value hierarchy.

The Company’s board of directors previously approved the plan to sell certain non-core business units.  Based upon the estimated fair values, the Company adjusted the carrying value of the assets and liabilities of the businesses to fair value.  Principle assumptions used in measuring the estimated value of assets and liabilities held for sale included estimated selling price of the discontinued business, discount rates, industry growth rates, and pricing of comparable transactions in the market.  The valuations are categorized as Level 3 in the fair value hierarchy.

Note 6 – Derivative Financial Instruments

The Company uses derivative financial instruments in the form of foreign currency forward exchange contracts and interest rate swap contracts for the purpose of minimizing exposure to changes in foreign currency exchange rates on business transactions and interest rates, respectively.  The Company’s policy is to execute such instruments with banks the Company believes to be creditworthy and not to enter into derivative financial instruments for speculative purposes.  These derivative financial instruments do not subject the Company to undue risk, as gains and losses on these instruments generally offset gains and losses on the underlying assets, liabilities, or anticipated transactions that are being hedged.

All derivative financial instruments are recorded at fair value in the Consolidated Balance Sheet.  For a derivative that has not been designated as an accounting hedge, the change in the fair value is recognized immediately through earnings.  For a derivative that has been designated as an accounting hedge of an existing asset or liability (a fair value hedge), the change in the fair value of both the derivative and underlying asset or liability is recognized immediately through earnings.  For a derivative designated as an accounting hedge of an anticipated transaction (a cash flow hedge), the change in the fair value is recorded on the Consolidated Balance Sheet in Accumulated Other Comprehensive Income (AOCI) to the extent the derivative is effective in mitigating the exposure related to the anticipated transaction.  The change in the fair value related to the ineffective portion of the hedge, if any, is immediately recognized in earnings.  The amount recorded within AOCI is reclassified into earnings in the same period during which the underlying hedged transaction affects earnings.

The fair value of derivative instruments is presented on a gross basis, as the Company does not have any derivative contracts which are subject to master netting arrangements.  The Company did not have any hedges with credit-risk-related contingent features or that required the posting of collateral as of December 29, 2017, and September 29, 2017.  The cash flows from derivative contracts are recorded in operating activities in the Consolidated Statement of Cash Flows.

Foreign Currency Forward Exchange Contracts

The Company transacts business in various foreign currencies, which subjects the Company’s cash flows and earnings to exposure related to changes in foreign currency exchange rates.  These exposures arise primarily from purchases or sales of products and services from third parties.  Foreign currency forward exchange contracts provide for the purchase or sale of foreign currencies at specified future dates at specified exchange rates, and are used to offset changes in the fair value of certain assets or liabilities or forecasted cash flows resulting from transactions denominated in foreign currencies.  At December 29, 2017, and September 29, 2017, the Company had outstanding foreign currency forward exchange contracts principally to sell U.S. dollars with notional amounts of $428.8 million and $406.9 million, respectively.  The notional value of our foreign currency forward contracts includes $69.2 million related to the hedge of a portion of our net monetary assets, including the embedded derivatives in our backlog.  These notional values consist primarily of contracts for the British pound sterling, Canadian dollar, and European euro and are stated in U.S. dollar equivalents at spot exchange rates at the respective dates.

10

Interest Rate Swaps

The Company manages its exposure to interest rate risk by maintaining an appropriate mix of fixed and variable rate debt, which over time should moderate the costs of debt financing.  When considered necessary, the Company may use financial instruments in the form of interest rate swaps to help meet this objective.

Embedded Derivative Instruments

The Company’s embedded derivatives are the result of entering into sales or purchase contracts that are denominated in a currency other than the Company’s functional currency or the supplier’s or customer’s functional currency.

Net Investment Hedge

In April 2015 the Company issued €330.0 million in 3.625% Senior Notes due April 2023 (2023 Notes) and requiring semi-annual interest payments in April and October each year until maturity.  The Company designated the 2023 Notes and accrued interest as a hedge of the investment of certain foreign business units.  The foreign currency gain or loss that is effective as a hedge is reported as a component of accumulated other comprehensive income (loss) in shareholders’ equity.  To the extent that this hedge is ineffective, the foreign currency gain or loss is recorded in earnings.  There was no ineffectiveness of the hedge since inception.

Fair Value of Derivative Instruments

Fair value of derivative instruments in the Consolidated Balance Sheet at December 29, 2017, and September 29, 2017, consisted of:

In Thousands		Fair Value
		December 29,		September 29,
	Classification	2017		2017
Foreign Currency Forward Exchange Contracts:
	Other current assets	$	11,708	$	11,433
	Other assets		2,458		2,783
	Accrued liabilities		1,653		2,506
	Other liabilities		156		398
Embedded Derivative Instruments:
	Other current assets	$	534	$	604
	Other assets		147		142
	Accrued liabilities		1,306		1,657
	Other liabilities		486		582

The effect of derivative instruments on the Consolidated Statement of Operations and Comprehensive Income (Loss) for the three-month periods ended December 29, 2017, and December 30, 2016, consisted of:

Fair Value Hedges and Embedded Derivatives

The Company recognized the following gains (losses) on contracts designated as fair value hedges and embedded derivatives:

In Thousands	Three Months Ended
Gain (Loss)	December 29,			December 30,
	2017			2016
Fair Value Hedges:
Recognized in cost of sales	$	(378	)	$	(933	)
Recognized in selling, general & administrative		(323	)		(768	)
Embedded derivatives:
Recognized in sales	$	345		$	253

Cash Flow Hedges

The Company recognized the following gains (losses) on contracts designated as cash flow hedges:

In Thousands	Three Months Ended
Gain (Loss)	December 29,			December 30,
	2017			2016
Foreign currency forward exchange contracts:
Recognized in AOCI (effective portion)	$	(2,493	)	$	(2,416	)
Reclassified from AOCI into sales		1,933			(4,425	)

11

Net Investment Hedges

The Company recognized the following gains (losses) on contracts designated as net investment hedges:

In Thousands	Three Months Ended
Gain (Loss)	December 29,			December 30,
	2017			2016
2023 Notes and Accrued Interest:
Recognized in AOCI	$	(6,297	)	$	23,913

During the first quarter of fiscal 2018 and 2017, the Company recorded a gain of $1.5 million and a loss of $0.9 million, respectively, on foreign currency forward exchange contracts that have not been designated as accounting hedges.  These foreign currency exchange gains and losses are included in selling, general and administrative expense.

There was no significant impact to the Company’s earnings related to the ineffective portion of any hedging instruments during the first quarter of fiscal 2018 and 2017.  In addition, there was no significant impact to the Company’s earnings when a hedged firm commitment no longer qualified as a fair value hedge or when a hedged forecasted transaction no longer qualified as a cash flow hedge during the first quarter of fiscal 2018 and 2017.

Amounts included in AOCI are reclassified into earnings when the hedged transaction settles.  The Company expects to reclassify approximately $10.9 million of net gain into earnings over the next 12 months.  The maximum duration of the Company’s foreign currency cash flow hedge contracts at December 29, 2017, was 24 months.

Note 7 – Insurance Recovery

In the first quarter of fiscal 2017, the Company received a $2.6 million insurance recovery resulting from an energetic incident at one of the Company’s countermeasure operations, which occurred in the first quarter of fiscal 2016.  The Company also received a $5.0 million insurance recovery in the fourth quarter of fiscal 2016 and $5.2 million in the second quarter of fiscal 2017 related to the energetic incident.  Management does not anticipate additional insurance recoveries arising from this matter in fiscal 2018.  The insurance recovery is reported as a separate line item on the Consolidated Statement of Operations and Comprehensive Income (Loss) and is included in Advanced Materials segment earnings.

Note 8 – License Fee Income

On December 22, 2017, the Company granted an exclusive license to a third party to manufacture, repair and sell certain legacy control devices for $3.0 million.  Additionally, the Company sold certain inventory and manufacturing equipment to the licensee for $1.0 million.  The Company will be paid a 15% royalty on future sales of the licensed product.  The license fee is reported as a separate line item on the Consolidated Statement of Operations and Comprehensive Income (Loss) and is included in Avionics & Controls segment earnings.

Note 9 – Income Taxes

The Tax Cuts and Jobs Act (the Act) was enacted on December 22, 2017.  The Act reduces the U.S. federal corporate tax rate from 35% to 21%, requires companies to pay a one-time transition tax on earnings of certain foreign subsidiaries that were previously tax deferred and creates new taxes on certain foreign sourced earnings.  

The SEC recognized that a company’s review of certain income tax effects of the Act may be incomplete at the time financial statements are issued.  Accordingly, the SEC issued Staff Accounting Bulletin 118, which provides that if a company does not have the necessary information available for certain effects of the Act, the Company may record provisional numbers and adjust those amounts during the measurement period not to extend beyond one year.

At December 29, 2017, the Company had not completed the accounting for the tax effects of enactment of the Act; however, in certain cases, as described below, the Company made a reasonable estimate of the effects on its existing deferred tax balances and the one-time transition tax.  In other cases, the Company was not able to make a reasonable estimate and continued to account for those items based on its existing accounting under ASC 740, Income Taxes, and the provisions of the tax laws that were in effect immediately prior to enactment.  For the items for which the Company was able to determine a reasonable estimate, the Company recognized a provisional amount of $48.6 million, which is included as a component of income tax expense from continuing operations.  In all cases, the Company will continue to make and refine the calculations as additional analysis is completed.  In addition, the estimates may also be affected as the Company gains a more thorough understanding of the tax law.

12

Provisional Amounts

U.S. Deferred Tax Assets and Liabilities

The Company remeasured certain deferred tax assets and liabilities based on the rates at which they are expected to reverse in the future, which is generally 21%.  However, the Company is still analyzing certain aspects of the Act and refining its calculations, including evaluation of limits on employee remuneration, which could affect the measurement of these balances or potentially give rise to new deferred tax amounts.  The provisional amount recorded related to the remeasurement of the deferred tax balance was $6.6 million.

Foreign Tax Effects

The one-time transition tax is based on the Company’s total post-1986 earnings and profits (E&P) that the Company previously deferred from U.S. income taxes.  The Company recorded a provisional amount for its one-time transition tax liability resulting in an increase in income tax expense of $42.0 million.  The Company is still analyzing certain aspects of the Act and refining its calculations, which could potentially affect the measurement of these amounts, including the benefit attributable to foreign tax credits and related elections.  Further, the transition tax is based in part on the amount of those earnings held in cash and other specified assets.  This amount may change when the Company finalizes the calculations of post-1986 foreign E&P previously deferred from U.S. taxation and finalizes the amounts of cash or other specified assets.  The Act sets certain limits that may restrict the Company’s use of any foreign tax credits generated from the one-time transaction tax.  As of the date of this report, management was not able to (1) determine a reasonable estimate of the tax liability for the Company’s remaining outside basis; (2) complete an analysis of the Global Intangible Low Taxed Income (GILTI); (3) determine the accounting for GILTI because ASC 740 is not clear whether GILTI will require the recording of deferred income tax expense; and (4) evaluate how the Act will impact the Company’s existing APB 23 position to indefinitely reinvest unremitted foreign earnings.  This could result in a material adjustment to the provisional income tax expense recorded in the first quarter of fiscal 2018.

The income tax rate for the first quarter of fiscal 2018 was 26.9% before the effect of the provisional taxes due to the Act and was 278.3% after the effect of the provisional taxes due to the Act.  The prior-year period was a benefit of 2.2%.  The Company conducts business in numerous tax jurisdictions, principally in the U.S., Canada, U.K. and France.  As a result, the Company’s income tax rate for the first fiscal quarter of 2018 reflects the estimated annual global effective tax rate, excluding discrete items, applied to year-to-date pre-tax earnings.

The following table summarizes the income tax rate for the first quarter of fiscal 2018 excluding and including the provisional taxes due to the Act.

In Thousands	Three Months Ended
	December 29, 2017
	Excluding			Including
Earnings from Continuing Operations Before Income Taxes	$	19,327		$	19,327
Income Tax Expense		5,573			5,573
Change in Tax Rate Due to the Act		(368	)		(368	)
Provisional Taxes Due to the Act		-			48,584
Total Income Tax Expense		5,205			53,789
Tax Rate		26.9	%		278.3	%

The income tax rate for the first quarter of fiscal 2018 reflected a blended U.S. tax rate of 24.5%, which is based upon an income tax rate of 35% for the Company’s first quarter of fiscal 2018 and 21% for the balance of the year ending September 28, 2018.

The 2.2% income tax rate in the first quarter of fiscal 2017 reflected the following items:  First, a reduction of the income tax rate in France for fiscal year 2020, which resulted in a reduction in the Company’s net deferred income tax liabilities of $3.8 million.  Second, $1.6 million of discrete tax benefits was recorded, primarily related to a valuation allowance release due to an expected taxable gain from a foreign income tax law change.  Third, the early adoption of the accounting standard update for employee share-based payment awards resulted in a $0.7 million tax benefit.

By the end of fiscal 2018, it is reasonably possible that approximately $1.4 million of tax benefits that are currently unrecognized could be recognized as a result of settlement of examinations and/or the expiration of applicable statutes of limitations.  The Company recognizes interest related to unrecognized tax benefits in income tax expense.

13

Note 10 – Debt

Long-term debt at December 29, 2017 and September 29, 2017, consisted of the following:

In Thousands	December 29,			September 29,
	2017			2017
U.S. credit facility	$	70,000		$	50,000
U.S. Term Loan, due April 2020		221,875			225,000
3.625% Senior Notes, due April 2023		396,099			389,862
Government refundable advances		45,464			45,549
Obligation under capital leases		70,693			71,091
Debt issuance costs		(4,415	)		(4,654	)
		799,716			776,848
Less current maturities		17,429			17,424
Carrying amount of long-term debt	$	782,287		$	759,424

U.S. Credit Facility

On April 9, 2015, the Company amended its secured credit facility to extend the maturity to April 9, 2020, increase the revolving credit facility to $500 million, and provide for a delayed-draw term loan facility of $250 million.  The Company recorded $2.3 million in debt issuance costs.  The credit facility is secured by substantially all the Company’s assets, and interest is based on standard inter-bank offering rates.  The interest rate ranges from LIBOR plus 1.25% to LIBOR plus 2.00% depending on leverage ratios at the time the funds are drawn.  At December 29, 2017, the Company had $70.0 million outstanding under the secured credit facility at an interest rate of LIBOR plus 1.50%, which was 2.82%. On February 13, 2018, the Company obtained a waiver and consent from the required lenders under the Company’s U.S. credit facilities of the financial reporting breaches resulting from the Restatement described in Note 2 of Company’s fiscal 2017 Form 10-K/A.

U.S. Term Loan, due April 2020

On August 3, 2015, the Company borrowed $250 million under the amended secured credit facility (U.S. Term Loan, due 2020).  The interest rate on the U.S. Term Loan, due 2020, ranges from LIBOR plus 1.25% to LIBOR plus 2.00%.  At December 29, 2017, the interest rate was LIBOR plus 1.50%, or 2.85%.  The loan amortizes at 1.25% of the original principal balance quarterly through March 2020, with the remaining balance due in April 2020.

3.625% Senior Notes, due April 2023

In April 2015 TA Mfg. Limited, a wholly owned subsidiary of the Company, issued €330.0 million in 3.625% Notes, due 2023 requiring semi-annual interest payments in April and October of each year until maturity.  The net proceeds from the sale of the notes, after deducting $5.9 million of debt issuance costs, were $350.8 million.  The 2023 Notes are general unsecured senior obligations of the Company.  The 2023 Notes are unconditionally guaranteed on a senior basis by the Company and certain subsidiaries of the Company that are guarantors under the Company’s existing secured credit facility.  The 2023 Notes are subject to redemption at the option of the Company at any time prior to April 15, 2018, at a price equal to 100% of the principal amount, plus any accrued interest to the date of redemption and a make-whole provision.  The Company may also redeem up to 35% of the 2023 Notes before April 15, 2018, with the net cash proceeds from equity offerings.  The 2023 Notes are also subject to redemption at the option of the Company, in whole or in part, on or after April 15, 2018, at redemption prices starting at 102.719% of the principal amount plus accrued interest during the period beginning April 15, 2018, and declining annually to 100% of principal and accrued interest on or after April 15, 2021.

Based on quoted market prices, the fair value of the Company’s 2023 Notes was $406.1 million and $403.2 million as of December 29, 2017, and September 29, 2017, respectively.  The carrying amount of the secured credit facility and the U.S. Term Loan, due 2020, approximate fair value.  The estimate of fair value for the 2023 Notes is based on Level 2 inputs as defined in the fair value hierarchy described in Note 5.

Government Refundable Advances

Government refundable advances consist of payments received from the Canadian government to assist in research and development related to commercial aviation.  The requirement to repay this advance is solely based on year-over-year commercial aviation revenue growth at CMC beginning in 2014.  Imputed interest on the advance was 2.52% at December 29, 2017.  The debt recognized was $45.5 million at December 29, 2017, and September 29, 2017.

Obligation Under Capital Lease

The Company leases building and equipment under capital leases.  The present value of the minimum capital lease payments, net of the current portion, totaled $68.6 million and $69.0 million as of December 29, 2017, and September 29, 2017, respectively.

14

Note 11 – Commitments and Contingencies

The Company is party to various lawsuits and claims, both as a plaintiff and defendant, and has contingent liabilities arising from the conduct of business, none of which, in the opinion of management, is expected to have a material effect on the Company’s financial position or results of operations.  The Company believes that it has made appropriate and adequate provisions for contingent liabilities.

On March 5, 2014, the Company entered into a Consent Agreement with the U.S. Department of State’s Directorate of Defense Trade Controls Office of Defense Trade Controls Compliance (DTCC) to resolve alleged International Traffic in Arms Regulations (ITAR) civil violations.  Among other things, the Consent Agreement required the Company to pay a $20 million penalty, of which $10 million was suspended and eligible for offset credit.  In fiscal 2016, the DTCC approved costs the Company incurred to implement compliance measures to fully offset the $10 million suspended payment.  The Consent Agreement was closed in fiscal 2017.

Note 12 – Employee Stock Plans

As of December 29, 2017, the Company had three share-based compensation plans, which are described below.  The compensation cost that has been charged against income for those plans was $4.0 million and $4.2 million for the first three months of fiscal 2018 and 2017, respectively.  During the first three months of fiscal 2018 and 2017, the Company issued 27,693 and 237,547 shares, respectively, under its share-based compensation plans.

Employee Stock Purchase Plan (ESPP)

The ESPP is a “safe-harbor” designed plan whereby shares are purchased by participants at a discount of 5% of the market value on the purchase date and, therefore, compensation cost is not recorded.

Employee Sharesave Scheme

The Company offers shares under its employee sharesave scheme for U.K. employees.  This plan allows participants the option to purchase shares at a 5% discount of the market price of the stock as of the beginning of the offering period.  The term of these options is three years.  The sharesave scheme is not a “safe-harbor” design, and therefore, compensation cost is recognized on this plan.  Under the sharesave scheme, option exercise prices are equal to the fair market value of the Company’s common stock on the date of grant.  There were no grants in the three-month periods ended December 29, 2017, and December 30, 2016.

Equity Incentive Plan

Under the equity incentive plan, option exercise prices are equal to the fair market value of the Company’s common stock on the date of grant.  The Company granted 197,700 and 231,100 options to purchase shares in the three-month periods ended December 29, 2017, and December 30, 2016, respectively.  The weighted-average grant date fair value of options granted during the three-month periods ended December 29, 2017, and December 30, 2016, was $31.20 and $32.55 per share, respectively.

The fair value of each option granted by the Company was estimated using a Black-Scholes pricing model, which uses the assumptions noted in the following table.  The Company uses historical data to estimate volatility of the Company’s common stock and option exercise and employee termination assumptions.  The risk-free rate for the contractual life of the option is based on the U.S. Treasury zero coupon issues in effect at the time of the grant.

	Three Months Ended
	December 29,	December 30,
	2017	2016
Volatility	34.32%	34.97 - 35.42%
Risk-free interest rate	2.15 - 2.47%	1.98 - 2.51%
Expected life (years)	5 - 9	5 - 9
Dividends	0	0

The Company granted 33,600 and 36,700 restricted stock units in the three-month periods ended December 29, 2017, and December 30, 2016, respectively.  The weighted-average grant date fair value of restricted stock units granted during the three-month periods ended December 29, 2017, and December 30, 2016, was $91.79 and $76.70 per share, respectively.  The fair value of each restricted stock unit granted by the Company is equal to the fair market value of the Company’s common stock on the date of grant.

The Company granted 33,700 and 42,100 performance share plan (PSP) shares in the three-month periods ended December 29, 2017, and December 30, 2016, respectively.  PSP shares will be paid out in shares of Esterline common stock at the end of the three year performance period.  The PSP shares granted in each period equaled the number of shares participants would receive if the Company achieves target performance over the relevant period.  The actual number of shares that will be paid out upon completion of the performance period is based on actual performance and may range from 0% to 300% of the target number of shares.

15

Note 13 – Discontinued Operations

The Company’s Board of Directors previously approved the plan to sell certain non-core business units including Wallop Defence Systems, Ltd. (Wallop), a manufacturer of flare countermeasure devices; a small distribution business; and a small manufacturing business.

On May 4, 2016, the Company sold certain assets of Wallop for 2.5 million British pounds and deferred consideration up to a maximum payment of 9 million British pounds.  In the definitive purchase and sale agreement for the sale of these assets, the Company provided standard representations and warranties as well as indemnification to the buyer of the Wallop operation.  The Company is obligated to indemnify the buyer for certain losses of up to 5.0 million British pounds, if, among other things, the Company breaches the representations and warranties.  In the first quarter of fiscal 2018, the Company received notification of a claim from the buyer of the Wallop operation alleging breaches of representations and warranties primarily associated with defective products and late product deliveries.  Although a loss is possible, the amount of any loss related to this claim cannot be estimated at this time.  The Company does not expect the possible loss to have a material effect on the Company’s financial position.  The deferred consideration is payable based upon receipt of acceptable orders during a three-year period ending May 3, 2019, and is equal to the amount of the acceptable order times a specified percentage ranging from 26.5% to 31%.  The earn-out payment is estimated to be 4.1 million British pounds, or $5.5 million, at December 29, 2017.  In December 2017 the buyer notified the Company that 1.3 million British pounds, or $1.8 million, of deferred consideration had been earned.

On March 28, 2017, the Company sold a small manufacturing business for $0.6 million and a note receivable of $2.4 million, resulting in a gain on sale of the business of $0.8 million.  The note receivable is due March 28, 2021, with an interest rate of 2.05%.

The Company incurred a $0.2 million loss from discontinued operations in the first quarter of fiscal 2018 compared to a $5.3 million loss from discontinued operations in the first quarter of fiscal 2017.

The operating results of the discontinued operations for the three-month period ended December 29, 2017, consisted of the following:

In Thousands	Avionics &			Sensors &		Advanced
	Controls			Systems		Materials			Other		Total
Net Sales	$	-		$	-	$	-		$	-	$	-
Operating earnings (loss)		14			-		(283	)		-		(269	)
Tax expense (benefit)		23			-		(126	)		-		(103	)
Income (loss) from discontinued    operations	$	(9	)	$	-	$	(157	)	$	-	$	(166	)
Included in Operating Earnings (Loss):
Gain (loss) on net assets    held for sale	$	(51	)	$	-	$	140		$	-	$	89

The operating results of the discontinued operations for the three-month period ended December 30, 2016, consisted of the following:

In Thousands	Avionics &			Sensors &		Advanced
	Controls			Systems		Materials			Other			Total
Net Sales	$	2,696		$	-	$	-		$	-		$	2,696
Operating earnings (loss)		(871	)		895		(5,347	)		(604	)		(5,927	)
Tax expense (benefit)		(239	)		-		(141	)		(211	)		(591	)
Income (loss) from discontinued    operations	$	(632	)	$	895	$	(5,206	)	$	(393	)	$	(5,336	)
Included in Operating Earnings (Loss):
Gain (loss) on net assets    held for sale	$	(140	)	$	-	$	(4,588	)	$	-		$	(4,728	)

16

Assets and Liabilities Held for Sale within the Consolidated Balance Sheet at December 29, 2017, are comprised of the following:

In Thousands	Avionics &		Sensors &		Advanced
	Controls		Systems		Materials		Total
Other current assets	$	-	$	-	$	2,834	$	2,834
Current Assets of Businesses Held for Sale		-		-		2,834		2,834
Net property, plant and equipment		5,262		-		-		5,262
Other assets		-		-		8,748		8,748
Non-Current Assets of Businesses Held for Sale		5,262		-		8,748		14,010
Accounts payable		-		-		54		54
Accrued liabilities		-		-		2,063		2,063
Current Liabilities of Businesses Held for Sale		-		-		2,117		2,117
Deferred income tax liabilities		-		-		2,752		2,752
Other liabilities		-		-		320		320
Non-Current Liabilities of Businesses Held for Sale		-		-		3,072		3,072
Net Assets of Businesses Held for Sale	$	5,262	$	-	$	6,393	$	11,655

Assets and Liabilities Held for Sale within the Consolidated Balance Sheet at September 29, 2017, were comprised of the following:

In Thousands	Avionics &		Sensors &		Advanced
	Controls		Systems		Materials		Total
Other current assets	$	-	$	-	$	6,501	$	6,501
Current Assets of Businesses Held for Sale		-		-		6,501		6,501
Net property, plant and equipment		5,262		-		-		5,262
Other assets		-		-		8,072		8,072
Non-Current Assets of Businesses Held for Sale		5,262		-		8,072		13,334
Accounts payable		-		-		138		138
Accrued liabilities		-		-		7,046		7,046
Current Liabilities of Businesses Held for Sale		-		-		7,184		7,184
Deferred income tax liabilities		-		-		1,404		1,404
Other liabilities		-		-		320		320
Non-Current Liabilities of Businesses Held for Sale		-		-		1,724		1,724
Net Assets of Businesses Held for Sale	$	5,262	$	-	$	5,665	$	10,927

17

Note 14 – Business Segment Information

Business segment information for continuing operations includes the segments of Avionics & Controls, Sensors & Systems and Advanced Materials.

In Thousands	Three Months Ended
	December 29,			December 30,
	2017			2016
Sales
Avionics & Controls	$	202,703		$	192,682
Sensors & Systems		175,468			167,756
Advanced Materials		103,874			97,978
	$	482,045		$	458,416
Earnings from Continuing Operations Before Income Taxes
Avionics & Controls	$	20,385		$	17,917
Sensors & Systems		11,713			18,143
Advanced Materials		14,583			9,880
Segment Earnings		46,681			45,940
Corporate expense		(20,048	)		(17,244	)
Interest income		298			96
Interest expense		(7,604	)		(7,888	)
	$	19,327		$	20,904

Note 15 – Subsequent Event

The Board of Directors approved the sale of the Company’s elastomer business based in Brea, California known as the Kirkhill business in March 2018.  On March 15, 2018, the Company sold the assets and certain liabilities of this business to TransDigm, Inc. for $50 million, before a working capital adjustment to be determined when the closing balance sheet of the business is finalized.  The Company expects to record a loss on sale ranging from $5 million to $7 million.

18

Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations

Overview

We operate our businesses in three segments:  Avionics & Controls, Sensors & Systems and Advanced Materials.  Our segments are structured around our technical capabilities.  Sales in all segments include domestic, international, defense and commercial customers.

The Avionics & Controls segment includes avionics systems, control and communication systems, and interface technologies capabilities.  The Sensors & Systems segment includes power systems, connection technologies and advanced sensors capabilities.  The Advanced Materials segment includes engineered materials and defense technologies capabilities.

Our current business and strategic plan focuses on the continued development and enhancement of our products principally for aerospace and defense markets.  We are concentrating our efforts to expand our capabilities in these markets, to anticipate the global needs of our customers, and to continually improve our operational performance.  These efforts focus on continuous research and new product development, acquisitions and strategic realignments of operations to offer more comprehensive solutions across our product offerings, and the implementation of the principles of our operating system to become a supplier of choice for our customers.

In March 2014 we entered into a Consent Agreement with the DTCC to resolve alleged ITAR civil violations.  Among other things, the Consent Agreement required us to pay a $20 million penalty, of which $10 million was suspended and eligible for offset credit.  In fiscal 2016 the DTCC approved costs we incurred to implement compliance measures to fully offset the $10 million suspended payment.  In fiscal 2017 the Consent Agreement was closed.

In fiscal 2014 our Board of Directors approved the plan to sell certain non-core business units including Eclipse Electronic Systems, Inc. (Eclipse), a manufacturer of embedded communication intercept receivers for signal intelligence applications; Wallop Defence Systems, Ltd. (Wallop), a manufacturer of flare countermeasure devices; a small distribution business; Pacific Aerospace and Electronics Inc. (PA&E), a manufacturer of hermetically sealed electrical connectors; and a small manufacturing business.  As of December 29, 2017, we have sold these business units, except for the land and building at Eclipse and Wallop, which are currently held for sale.  These businesses are reported as discontinued operations.

In fiscal 2017 we evaluated the on-going performance challenges at our elastomer business based in Brea, California known as the Kirkhill business, resulting in the decision to explore all strategic options associated with the business.  The historic performance volatility of this business was a consideration in this decision.  In the first quarter of fiscal 2018, the results of operations of the Kirkhill business declined by $1.1 million from the prior-year period.  We recorded a loss associated with this business of $6.0 million, primarily reflecting lower sales volumes of certain defense products under a new long-term contract which replaced a higher priced product.  In March 2018 the Board of Directors approved the sale of the Kirkhill business and on March 15, 2018, we sold the assets and certain liabilities of this business to TransDigm, Inc. for $50 million before a working capital adjustment to be determined when the closing balance sheet is finalized.  The loss on sale is estimated to range between $5 million and $7 million.

On June 19, 2014, our Board of Directors approved a share repurchase program and authorized the repurchase of up to $200 million of outstanding shares of common stock.  In March 2015 our Board of Directors authorized an additional $200 million for the repurchase of outstanding shares of common stock under the program.  Under the program, the Company is authorized to repurchase up to $400 million of the outstanding shares of common stock from time to time, depending on market conditions, share price and other factors.  In the first quarter of fiscal 2018, we repurchased 287,500 shares under this program at an average price paid per share of $71.11, for an aggregate purchase price of $20.4 million.  There were no shares repurchased in the first quarter of fiscal 2017.  Subsequent to December 29, 2017, we repurchased 313,900 shares under this program at an average price paid per share of $73.29, for an aggregate purchase price of $23.0 million.  Since the program began, the Company has repurchased 3,737,327 shares for an aggregate purchase price of $352.0 million, with $48.0 million in shares remaining available for repurchase in the future.

Sales for the first quarter of fiscal 2018 increased $23.6 million to $482.0 million over the prior-year period due mainly to increased sales across all segments.

Gross margin was 30.8% in the first quarter of fiscal 2018 compared with 31.2% in the prior-year period.  Gross profit was $148.3 million and $142.9 million for the first quarter of fiscal 2018 and 2017, respectively.  For further explanation about changes in sales and gross profit in the first quarter of fiscal 2018 over the prior-year period, refer to the table at the end of this Overview section.

Selling, general and administrative expenses increased by $3.8 million in the first quarter of fiscal 2018 over the prior-year period to $98.9 million.

Research, development and engineering expense increased by $4.1 million to $25.8 million, or 5.4% of sales, in the first quarter of fiscal 2018 from the prior-year period.  The increase mainly reflected higher expense at Avionics & Controls and Sensors & Systems.

On December 22, 2017, we granted an exclusive license to a third party to manufacture, repair and sell certain legacy control devices for $3.0 million.  Additionally, we sold certain inventory and manufacturing equipment to the licensee for $1.0 million.  We will be

19

paid a 15% royalty on future sales of the licensed product.  The license fee is reported as a separate line item on the Consolidated Statement of Operations and Comprehensive Income (Loss) and is included in Avionics & Controls segment earnings.

In the first quarter of fiscal 2017, we received a $2.6 million insurance recovery resulting from an energetic incident at one of our countermeasure operations, which occurred in the first quarter of fiscal 2016.  We also received a $5.0 million insurance recovery in the fourth quarter of fiscal 2016 and $5.2 million in the second quarter of fiscal 2017 related to the energetic incident.  We do not anticipate additional insurance recoveries arising from this matter in fiscal 2018.  The insurance recovery is reported as a separate line item on the Consolidated Statement of Operations and Comprehensive Income (Loss) and is included in Advanced Materials segment earnings.

As explained in Note 9 to the Consolidated Financial Statements included in Part 1, Item 1 of this report, the Tax Cuts and Jobs Act (the Act) was enacted on December 22, 2017.  The Act reduces the U.S. federal corporate tax rate from 35% to 21%, requires companies to pay a one-time transition tax on earnings of certain foreign subsidiaries that were previously tax deferred and creates new taxes on certain foreign sourced earnings.  At December 29, 2017, we had not completed our accounting for the tax effects of enactment of the Act; however, we made a reasonable estimate of the effects on our existing deferred tax balances and the one-time transition tax based on our total post-1986 earnings and profits that we previously deferred from U.S. income tax.  We recorded a provisional amount related to the remeasurement of our deferred income tax balance of $6.6 million and a provisional amount related to our one-time transition tax liability of $42.0 million.

The income tax rate for the first quarter of fiscal 2018 was 26.9% before the effect of the Act and 278.3% after the effect of the Act.  The prior-year period was a tax benefit of 2.2%.  The 278.3% tax rate reflects the provisional amounts described above.  The income tax rate in the first quarter of fiscal 2017 benefited from certain discrete income tax benefits mainly due to a reduction in the income tax rate in France in 2020.

We reported a loss from continuing operations in the first quarter of fiscal 2018 of $34.8 million, or $1.16 per diluted share, compared with earnings from continuing operations of $21.1 million, or $0.71 per diluted share, in the prior-year period due to the $48.6 million, or $1.63 per diluted share, income charge resulting from the Act.

As explained in Note 13 to the Consolidated Financial Statements included in Part 1, Item 1 of this report, in fiscal 2014, our Board of Directors previously approved the plan to sell certain non-core business units including Wallop Defence Systems, Ltd. (Wallop), a manufacturer of flare countermeasure devices; a small distribution business; and a small manufacturing business.  On March 28, 2017, we sold a small manufacturing business for $0.6 million and a note receivable of $2.4 million, resulting in a gain on sale of the business of $0.8 million.  In May 2016, we sold certain assets of Wallop and in June 2016 entered into an agreement to sell Wallop’s naval business which closed in the first quarter of fiscal 2018.  In June 2017, we sold additional assets of Wallop for 0.7 million euros, or $0.8 million.  These businesses are reported as discontinued operations.

Loss from discontinued operations in the first quarter of fiscal 2018 was $0.2 million, or $0.01 per diluted share, compared with a loss of $5.3 million, or $0.18 per diluted share, in the prior-year period.

Net loss in the first quarter of fiscal 2018 was $35.0 million, or $1.17 per diluted share, compared with net earnings of $15.8 million, or $0.53 per diluted share, in the prior-year period.

Cash flows from operating activities were $62.4 million in the first three months of fiscal 2018 compared with $45.5 million in the prior-year period.  The increase in cash flows from operating activities is primarily from higher cash receipts on accounts receivable and lower payments on accounts payable.

Our sales, gross margin and earnings results for the first quarter of fiscal 2018 compared with the prior-year period included a number of significant items which are summarized in the tables below.

20

The following is a roll forward of sales and gross margin from the three-month period ended December 30, 2016, to the three-month period ended December 29, 2017:

In Thousands	Avionics &			Sensors &			Advanced
	Controls			Systems			Materials		Total
Sales:
Three-month period ended December 30, 2016	$	192,682		$	167,756		$	97,978	$	458,416
Foreign currency gain (loss)		2,579			6,504			1,465		10,548
Forward contract gain (loss)		3,820			2,456			-		6,276
Sales volume		3,622			(1,248	)		4,431		6,805
Three-month period ended December 29, 2017	$	202,703		$	175,468		$	103,874	$	482,045
Gross Margin:
Three-month period ended December 30, 2016		60,488			57,971			24,453		142,912
Foreign currency gain (loss)		(42	)		767			376		1,101
Forward contract gain (loss)		3,882			2,456			-		6,338
Volume/mix		1,389			(4,781	)		2,283		(1,109	)
Lower (higher) manufacturing costs		(13	)		607			697		1,291
Business integration		301			-			-		301
Inventory cost and EAC adjustment		-			55			1,195		1,250
Other		(1,688	)		(2,060	)		-		(3,748	)
Three-month period ended December 29, 2017	$	64,317		$	55,015		$	29,004	$	148,336

The following table shows the average foreign exchange rates for the British pound, Canadian dollar and European euro relative to the U.S. dollar for the three-month periods ended December 29, 2017, and December 30, 2016.

	Three Months Ended
	December 29,		December 30,
	2017		2016		Change
GBP to USD		1.3305		1.2441		6.9	%
CAD to USD		0.7889		0.7463		5.7	%
EUR to USD		1.1817		1.0819		9.2	%

The following table shows the impact of changes in the foreign currency exchange rates for the British pound, Canadian dollar and European euro relative to the U.S. dollar on operating earnings during the three-month period ended December 29, 2017, compared with the prior-year period.

In Thousands	Avionics &			Sensors &			Advanced
	Controls			Systems			Materials			Total
Foreign currency gain (loss)	$	(3,047	)	$	(2,623	)	$	(598	)	$	(6,268	)
Forward contract gain (loss)		4,582			2,885			2,218			9,685
Impact on Operating Earnings (Loss)	$	1,535		$	262		$	1,620		$	3,417

21

Results of Operations

Three-Month Period Ended December 29, 2017, Compared with Three-Month Period Ended December 30, 2016

Total sales for the first three months of fiscal 2018 increased by $23.6 million, or 5.2%, over the prior-year period.  Sales by segment were as follows:

In Thousands		Three Months Ended
	Increase (Decrease)	December 29,		December 30,
	From Prior Year	2017		2016
Avionics & Controls	5.2%	$	202,703	$	192,682
Sensors & Systems	4.6%		175,468		167,756
Advanced Materials	6.0%		103,874		97,978
Total Net Sales		$	482,045	$	458,416

The $10.0 million increase in Avionics & Controls sales over the prior-year period mainly reflected the following:

• Higher sales volumes of $7 million in control and communication systems principally for the P-8 program and cockpit components for legacy aircraft

• Higher sales of avionics systems of $2 million mainly for defense applications

• Favorable effect of changes in foreign currency exchange rates of $6 million

• Partially offset by lower sales of interface technologies of $5 million, principally for medical and industrial applications nearing end of life

The $7.7 million increase in Sensor & Systems sales over the prior-year period principally reflected the following:

• Favorable effect of changes in foreign currency exchange rates of $9 million

• Higher sales of advanced sensors for the aftermarket in Europe and Asia of $2 million

• Higher sales of power systems for rail applications in Asia of $5 million

• Partially offset by lower sales of power systems of $8 million principally due to the completion of an FAA requirement for ground fault indicators in fiscal 2017 and lower spare sales for the A400M program

The $5.9 million increase in sales in Advanced Materials over the prior-year period mainly reflected the following:

• Higher sales volumes of defense technologies of $5 million mainly due to the return to full production of one of our countermeasure operations following an energetic incident in May 2016

• Favorable effect of changes in foreign currency exchange rates of $1 million

Overall, gross margin was 30.8% and 31.2% for the first three months of fiscal 2018 and 2017, respectively.  Gross profit was $148.3 million and $142.9 million for the first three months of fiscal 2018 and 2017, respectively.  Gross profit and gross margin percentage by segment were as follows:

In Thousands		Three Months Ended
	Increase (Decrease)	December 29,			December 30,
	From Prior Year	2017			2016
Avionics & Controls	6.3%	$	64,317		$	60,488
Sensors & Systems	(5.1)%		55,015			57,971
Advanced Materials	18.6%		29,004			24,453
Total Gross Profit		$	148,336		$	142,912
Avionics & Controls	0.3%		31.7	%		31.4	%
Sensors & Systems	(3.2)%		31.4	%		34.6	%
Advanced Materials	2.9%		27.9	%		25.0	%
Gross Margin Percentage			30.8	%		31.2	%

The $3.8 million increase in Avionics & Controls gross profit is mainly due to the favorable effect of changes in foreign currency rates.

The $3.0 million decrease in Sensors & Systems gross profit principally reflected the following:

• Unfavorable product mix of $5 million mainly on sales of power systems

22

• Higher other expenses of $1 million due to increased penalty expenses on late shipments of advanced sensors

• Partially offset by the favorable effect of changes in foreign currency rates of $3 million

The $4.6 million increase in Advanced Materials gross profit principally reflected the following:

• Higher sales volume/mix mainly due to higher sales of countermeasures of $5 million

• Lower manufacturing costs of engineered materials of $1 million and an unfavorable contract loss recorded in the prior-year period of $1 million

• Partially offset by unfavorable product mix on sales of engineered materials of $3 million

Selling, general and administrative expenses (which include corporate expenses) totaled $98.9 million, or 20.5% of sales, and $95.1 million, or 20.7% of sales, for the first three months of fiscal 2018 and 2017, respectively.  The increase in selling, general and administrative expense was mainly due to the unfavorable effect changes in foreign currency rates of $3 million.

Research, development and engineering spending was $25.8 million, or 5.4% of sales, for the first three months of fiscal 2018 compared with $21.7 million, or 4.7% of sales, for the first three months of fiscal 2017.  The $4.1 million increase in research, development and engineering principally reflected higher spending in the Avionics & Controls and Sensors & Systems segments in the first three months of fiscal 2018.  Management expects that the full year research, development and engineering expense will be approximately 5% of sales.

Segment earnings (operating earnings excluding corporate expenses and other income or expense) for the first three months of fiscal 2018 totaled $46.7 million, or 9.7% of sales, compared with $45.9 million, or 10.0% of sales, for the first three months in fiscal 2017.  Segment earnings by segment were as follows:

In Thousands		Three Months Ended
	Increase (Decrease)	December 29,			December 30,
	From Prior Year	2017			2016
Avionics & Controls	13.8%	$	20,385		$	17,917
Sensors & Systems	(35.4)%		11,713			18,143
Advanced Materials	47.6%		14,583			9,880
Total Segment Earnings		$	46,681		$	45,940
Avionics & Controls	0.8%		10.1	%		9.3	%
Sensors & Systems	(4.1)%		6.7	%		10.8	%
Advanced Materials	3.9%		14.0	%		10.1	%
Segment Earnings Percentage			9.7	%		10.0	%

The $2.5 million increase in Avionics & Controls segment earnings mainly reflected the following:

• A $4 million increase in gross profit

• A $3 million license fee from licensing certain legacy avionics controls to a third-party manufacturer

• Partially offset by:

• A $2 million increase in research, development and engineering for mainly avionics systems applications

• A $2 million unfavorable effect of changes in foreign currency exchange rates on operating expenses

The $6.4 million decrease in Sensors & Systems segment earnings mainly reflected the following:

• A $2 million decrease in gross profit

• A $3 million unfavorable effect of changes in foreign currency exchange rates

• A $1 million increase in research, development and engineering

The $4.7 million increase in Advanced Materials segment earnings reflected an increase in gross profit on higher sales volumes.

Interest expense for the first three months of fiscal 2018 was $7.6 million compared with $7.9 million for the first three months of fiscal 2017.  The decrease in interest expense mainly reflected lower borrowings, partially offset by a higher interest rate.

As explained in Note 9 to the Consolidated Financial Statements included in Part 1, Item 1 of this report, the Tax Cuts and Jobs Act (the Act) was enacted on December 22, 2017.  We recorded a provisional amount related to the remeasurement of our deferred income tax balance of $6.6 million and a provisional amount related to our one-time transition tax liability of $42.0 million.  We expect that the provisional tax liability of $42.0 million will be paid over an eight-year period.

23

The income tax rate for the first quarter of fiscal 2018 before the effect of the provisional taxes due to the Act was 26.9% and was 278.3% after the effect of the Act.  The prior year period was a tax benefit of 2.2%.  The following table summarizes the income tax rate for the first quarter of fiscal 2018 excluding and including the provisional taxes due to the Act.

In Thousands	Three Months Ended
	December 29, 2017
	Excluding			Including
Earnings from Continuing Operations Before Income Taxes	$	19,327		$	19,327
Income Tax Expense		5,573			5,573
Change in Tax Rate Due to the Act		(368	)		(368	)
Provisional Taxes Due to the Act		-			48,584
Total Income Tax Expense		5,205			53,789
Tax Rate		26.9	%		278.3	%

The income tax rate for the first quarter of fiscal 2018 reflected a blended U.S. tax rate of 24.5%, which is based upon an income tax rate of 35% for our first quarter of fiscal 2018 and 21% for the balance of year ending September 28, 2018.

The 2.2% income tax rate in the first quarter of fiscal 2017 reflected the following items:  First, a reduction of the income tax rate in France for fiscal year 2020 resulted in a reduction in the Company’s net deferred income tax liabilities of $3.8 million.  Second, $1.2 million of discrete tax benefits was recorded, primarily related to a valuation allowance release due to an expected taxable gain from a foreign income tax law change.  Third, the early adoption of the accounting standard update for employee share-based payment awards resulted in a $0.7 million tax benefit.

We estimate that our income tax rate for fiscal 2018, excluding the one-time transition income tax amount of $48.6 million, will range from 25% to 27%.  Our income tax rate for fiscal 2018 reflects the fact that a significant portion of our earnings from continuing operations before income taxes is earned by our foreign operations and the income tax rate for these foreign operations will range from 26% to 27%.

During the next 12 months, it is reasonably possible that approximately $1.4 million of tax benefits that are currently unrecognized could be recognized as a result of settlement of examinations and/or the expiration of applicable statutes of limitations.  We recognize interest related to unrecognized tax benefits in income tax expense.

Backlog was $1.4 billion at December 29, 2017, $1.3 billion at September 29, 2017, and $1.3 billion at December 30, 2016.  New orders for the first three months of fiscal 2018 were approximately $565.8 million compared with $421.9 million in the prior-year period due mainly to an increase in all segments.  The increase in orders reflects strong demand across all three segments, mainly for orders scheduled to be shipped beyond fiscal 2018.

Liquidity and Capital Resources

Cash and cash equivalents at December 29, 2017, totaled $354.9 million, an increase of $47.0 million from September 29, 2017.  Net working capital increased to $902.6 million at December 29, 2017, from $874.9 million at September 29, 2017.  Sources and uses of cash flows from operating activities principally consisted of cash received from the sale of products and cash payments for material, labor and operating expenses.

Cash flows provided by operating activities were $62.4 million and $45.5 million in the first three months of fiscal 2018 and 2017, respectively.  The increase in cash flows from operating activities is primarily from higher cash receipts on accounts receivable and lower payments on accounts payable.

Cash flows used by investing activities were $13.4 million and $15.3 million in the first three months of fiscal 2018 and 2017, respectively, and were primarily for capital expenditures.

Cash flows used by financing activities were $3.0 million in the first three months of fiscal 2018, mainly reflecting:

• $20.4 million for shares repurchased

• $5.0 million repayment of borrowing under our long-term credit facilities

• $3.6 million repayment of long-term debt

• Partially offset by:

• $25.0 million in proceeds from borrowing under our long-term credit facilities

• $1.2 million in proceeds from the issuance of common stock under our employee stock plans

24

Cash flows provided by financing activities were $1.8 million in the first three months of fiscal 2017 and mainly reflected:

• $10.0 million repayment of long-term credit facilities

• $3.1 million repayment of long-term debt

• Partially offset by:

• $10.7 million in proceeds from the issuance of common stock under our employee stock plans

• $5.0 million in proceeds from borrowing under our long-term credit facilities

Capital expenditures, consisting of building, machinery, equipment and computers, are anticipated to be between $80 million to $85 million during fiscal 2018, compared with $58.0 million expended in fiscal 2017.

Total debt at December 29, 2017, was $799.7 million and consisted of $221.9 million of the U.S. Term Loan, due 2020, $396.1 million (€330.0 million) of the 2023 Notes, $70.0 million in borrowings under our secured credit facility, $70.6 million under capital lease obligations, $45.5 million in government refundable advances and net of debt issuance costs of $4.4 million.  On February 13, 2018, we obtained a waiver and consent from the required lenders under the Company’s U.S. credit facilities of the financial reporting breaches resulting from the Restatement described in Note 2 of Company’s fiscal 2017 Form 10-K/A.

We expect that the provisional tax liability of $42.0 million will be paid over an eight-year period.

We believe cash on hand and funds generated from operations and borrowing capacity available under our debt facilities are sufficient to fund operating cash requirements and capital expenditures through the next twelve months.

Forward-Looking Statements

This quarterly report on Form 10-Q contains forward-looking statements.  These statements relate to future events or our future financial performance.  In some cases you can identify forward-looking statements by terminology such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “potential,” “predict,” “should” or “will” or the negative of such terms or other comparable terminology.  These statements are only predictions and involve known and unknown risks, uncertainties and other factors, including the risk factors set forth in “Forward-Looking Statements” and “Risk Factors” in our Report on Form 10-K/A for the fiscal year ended September 29, 2017, that may cause our or the industry’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements.  You should not place undue reliance on these forward-looking statements.  Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, performance or achievements.  Given these risks and uncertainties, you are cautioned not to place undue reliance on such forward-looking statements.  The forward-looking statements included or incorporated by reference into this report are made only as of the date hereof.  We do not undertake and specifically decline any obligation to update any such statements or to publicly announce the results of any revisions to any such statements to reflect future events or developments.

Item 3.               Quantitative and Qualitative Disclosures About Market Risk

There have been no significant changes in our exposure to market risk during the first three months of fiscal 2018.  A discussion of our exposure to market risk is provided in the Company’s Report on Form 10-K/A for the fiscal year ended September 29, 2017.

Item 4.               Controls and Procedures

Our principal executive and financial officers evaluated our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of December 29, 2017.  As described in Management’s Report on Internal Control over Financial Reporting in Item 9A of the Company’s Annual Report on Form 10-K/A for the fiscal year ended September 29, 2017, we reported two material weaknesses in internal control over financial reporting that existed as of September 29, 2017.  

Financial personnel at our U.S. power systems business unit directed financial accountants to make improper accounting entries in the financial records, which were contrary to our internal accounting policies and circumvented our internal controls over the reconciliation of intercompany charges between our French and U.S. power systems business units.  In addition, our monitoring controls at our power systems business units failed to detect these errors, and accordingly, our control over the review and approval of power systems financial statements and intercompany account reconciliations was not effective.  These material weaknesses resulted in misstatements in the financial results for fiscal 2017, fiscal 2016 and fiscal 2015 reported in our annual report on Form 10-K for fiscal 2017 filed on November 21, 2017, with the Securities and Exchange Commission and required adjustments that were included in our fiscal 2017 Form 10-K/A.

These material weaknesses in our internal control over financial reporting were not remediated as of December 29, 2017.  As a result, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of December 29, 2017.

25

Remediation of Material Weaknesses

The Board of Directors and management are fully committed to maintaining a strong internal control environment.  The Company has taken and will continue to take significant and comprehensive actions to remediate the material weaknesses in internal control over financial reporting.

Our power systems business units will implement our policies and procedures over the reconciliation of intercompany transactions.  We continue to monitor the reconciliation control execution and will make further changes as necessary.  Additionally, we are enhancing our monitoring controls and analytical procedures over reviewing business unit financial statements.

We replaced the financial staff at our U.S.-based power systems unit with a new platform finance director, unit finance director and controller with appropriate levels of experience.

PART II – OTHER INFORMATION

Item 1.               Legal Proceedings

From time to time we are involved in legal proceedings arising in the ordinary course of business.  We believe that adequate reserves for these liabilities have been made and that there is no litigation pending that could have a material adverse effect on our results of operations and financial condition.

See Note 11 to the Consolidated Financial Statements included in Part 1, Item 1 of this report for information regarding legal proceedings.

Item 2.               Unregistered Sales of Equity Securities and Use of Proceeds

(a) Not applicable.

(b) Not applicable.

(c) Purchases of Equity Securities by the Issuer and Affiliated Purchasers

					Total Number of		Dollar Value
					Shares Purchased		of Shares
					as Part of		That May Yet
	Total Number		Average		Publicly		Be Purchased
	of Shares		Price Paid		Announced Plans		Under the Plans
Period	Repurchased		Per Share		or Programs		or Programs
September 30, 2017 to October 27, 2017		-	$	-		3,135,927	$	91,485,852
October 28, 2017 to November 24, 2017		75,000		70.85		3,210,927		86,171,940
November 25, 2017 to December 29, 2017		212,500		71.21		3,423,427		71,040,787
Total		287,500

On June 19, 2014, our Board of Directors approved a $200 million share repurchase program.  On March 11, 2015, our Board of Directors approved an additional $200 million for the share repurchase program.  Under the program, the Company is authorized to repurchase up to $400 million of outstanding shares of common stock from time to time, depending on market conditions, share price and other factors.  All of the repurchases in the table above were made under that program.

26

Item 6.Exhibits

Exhibit
Number		Exhibit Index
10.1	*	Esterline Technologies Corporation Fiscal Year 2018 Annual Incentive Compensation Plan.  (Incorporated by reference to Exhibit 10.1 to the Company's Annual Report on Form 10-K for the year ended September 29, 2017 [Commission File Number 1-6357].)
10.2	*	Esterline Technologies Corporation Long-Term Incentive Performance Share Plan, for fiscal years 2018 – 2020.  (Incorporated by reference to Exhibit 10.2 to the Company's Annual Report on Form 10-K for the year ended September 29, 2017 [Commission File 1-6357].)
11		Schedule setting forth computation of basic and diluted earnings (loss) per share for the three month periods ended December 29, 2017, and December 30, 2016.
31.1		Certification of Chief Executive Officer.
31.2		Certification of Chief Financial Officer.
32.1		Certification (of Curtis C. Reusser) pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2		Certification (of Stephen M. Nolan) pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS		XBRL Instance Document
101.SCH		XBRL Taxonomy Extension Schema
101.CAL		XBRL Taxonomy Extension Calculation Linkbase
101.DEF		XBRL Taxonomy Extension Definition Linkbase
101.LAB		XBRL Taxonomy Extension Label Linkbase
101.PRE		XBRL Taxonomy Extension Presentation Linkbase

* Indicates management contract or compensatory plan or arrangement.

27

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

ESTERLINE TECHNOLOGIES CORPORATION

    (Registrant)

Dated: March 30, 2018	By:	/s/ Stephen M. Nolan
		Stephen M. Nolan
		Executive Vice President and Chief Financial Officer
		(Principal Financial Officer)

28

EX-11

EXHIBIT 11

ESTERLINE TECHNOLOGIES CORPORATION

Computation of Basic and Diluted Earnings (Loss) Per Common Share

For the Three Month Periods Ended December 29, 2017, and December 30, 2016

(Unaudited)

(In thousands, except per share amounts)

	Three Months Ended
	December 29,			December 30,
	2017			2016
Basic
Weighted Average Number of Shares Outstanding		29,903			29,547
Earnings (Loss) Per Share Attributable to Esterline - Basic:
Continuing Operations	$	(1.16	)	$	0.71
Discontinued Operations		(0.01	)		(0.18	)
Earnings (Loss) Per Share	$	(1.17	)	$	0.53
Diluted
Weighted Average Number of Shares Outstanding		29,903			29,547
Net Shares Assumed to be Issued for Stock Options and RSUs		-			284
Weighted Average Number of Shares and Equivalent Shares Outstanding - Diluted		29,903			29,831
Earnings (Loss) Per Share Attributable to Esterline - Diluted:
Continuing Operations	$	(1.16	)	$	0.71
Discontinued Operations		(0.01	)		(0.18	)
Earnings (Loss) Per Share	$	(1.17	)	$	0.53

EX-31.1

EXHIBIT 31.1

CERTIFICATIONS

I, Curtis C. Reusser, certify that:

1.  I have reviewed this quarterly report on Form 10-Q of Esterline Technologies Corporation;

2.  Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

3.  Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report.

4.  The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.  The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: March 30, 2018	By:	/s/ Curtis C. Reusser
		Curtis C. Reusser
		Chairman, President and Chief Executive Officer
		(Principal Executive Officer)

EX-31.2

EXHIBIT 31.2

CERTIFICATIONS

I, Stephen M. Nolan, certify that:

1.  I have reviewed this quarterly report on Form 10-Q of Esterline Technologies Corporation;

2.  Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

3.  Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report.

4.  The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.  The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: March 30, 2018	By:	/s/ Stephen M. Nolan
		Stephen M. Nolan
		Executive Vice President and Chief Financial Officer
		(Principal Financial Officer)

EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Esterline Technologies Corporation (the “Company”) on Form 10-Q for the period ended December 29, 2017, as filed with the Securities and Exchange Commission on the date hereof (the “Form 10-Q”), I, Curtis C. Reusser, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Form 10-Q fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

(2) The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: March 30, 2018	By:	/s/ Curtis C. Reusser
		Curtis C. Reusser
		Chairman, President and Chief Executive Officer

EX-32.2

EXHIBIT 32.2

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Esterline Technologies Corporation (the “Company”) on Form 10-Q for the period ended December 29, 2017, as filed with the Securities and Exchange Commission on the date hereof (the “Form 10-Q”), I, Stephen M. Nolan, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Form 10-Q fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

(2) The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: March 30, 2018	By:	/s/ Stephen M. Nolan
		Stephen M. Nolan
		Executive Vice President and Chief Financial Officer

XML

Document and Entity Information - shares	3 Months Ended
	Dec. 29, 2017	Mar. 27, 2018
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Dec. 29, 2017
Document Fiscal Year Focus	2018
Document Fiscal Period Focus	Q1
Trading Symbol	ESL
Entity Registrant Name	ESTERLINE TECHNOLOGIES CORP
Entity Central Index Key	0000033619
Current Fiscal Year End Date	--09-28
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		29,426,691

XML

CONSOLIDATED BALANCE SHEET (Unaudited) - USD ($) $ in Thousands	Dec. 29, 2017	Sep. 29, 2017
Current Assets
Cash and cash equivalents	$ 354,872	$ 307,826
Accounts receivable, net of allowances of $15,777 and $16,035	374,700	430,524
Inventories
Raw materials and purchased parts	200,441	194,034
Work in progress	182,469	178,191
Finished goods	113,657	105,744
Inventories	496,567	477,969
Income tax refundable	8,487	12,814
Prepaid expenses	22,762	19,239
Other current assets	14,345	13,836
Current assets of businesses held for sale	2,834	6,501
Total Current Assets	1,274,567	1,268,709
Property, Plant and Equipment	874,752	862,715
Accumulated depreciation	528,119	514,081
Total Property, Plant and Equipment	346,633	348,634
Other Non-Current Assets
Goodwill	1,058,293	1,053,573
Intangibles, net	350,005	359,166
Deferred income tax benefits	51,327	56,793
Other assets	20,221	19,804
Non-current assets of businesses held for sale	14,010	13,334
Total Assets	3,115,056	3,120,013
Current Liabilities
Accounts payable	133,656	138,595
Accrued liabilities	217,251	230,007
Current maturities of long-term debt	17,429	17,424
U.S. and foreign income taxes	1,501	582
Current liabilities of businesses held for sale	2,117	7,184
Total Current Liabilities	371,954	393,792
Long-Term Liabilities
Credit facilities	70,000	50,000
Long-term debt, net of current maturities	712,287	709,424
Deferred income tax liabilities	42,507	43,978
Pension and post-retirement obligations	66,465	66,981
Long-term U.S. income taxes payable	38,640	0
Other liabilities	18,435	18,838
Non-current liabilities of businesses held for sale	3,072	1,724
Shareholders' Equity
Common stock, par value $.20 per share, authorized 60,000,000 shares, issued 33,145,166 and 33,117,473 shares	6,629	6,623
Additional paid-in capital	743,274	738,329
Treasury stock at cost, repurchased 3,423,427 and 3,135,927 shares	(328,959)	(308,514)
Retained earnings	1,620,206	1,655,187
Accumulated other comprehensive loss	(260,421)	(266,870)
Total Esterline Shareholders' Equity	1,780,729	1,824,755
Noncontrolling interests	10,967	10,521
Total Shareholders' Equity	1,791,696	1,835,276
Total Liabilities and Shareholders' Equity	$ 3,115,056	$ 3,120,013

XML

CONSOLIDATED BALANCE SHEET (Parenthetical) (Unaudited) - USD ($) $ in Thousands	Dec. 29, 2017	Sep. 29, 2017
Statement Of Financial Position [Abstract]
Accounts receivable, allowances	$ 15,777	$ 16,035
Common stock, par value	$ 0.20	$ 0.20
Common stock, shares authorized	60,000,000	60,000,000
Common stock, shares issued	33,145,166	33,117,473
Treasury stock, shares repurchased	3,423,427	3,135,927

XML

CONSOLIDATED STATEMENT OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Dec. 29, 2017	Dec. 30, 2016
Income Statement [Abstract]
Net Sales	$ 482,045	$ 458,416
Cost of Sales	333,709	315,504
Gross Profit	148,336	142,912
Expenses
Selling, general & administrative	98,886	95,110
Research, development and engineering	25,842	21,706
Insurance recovery	0	(2,600)
License fee income	(3,025)	0
Total Expenses	121,703	114,216
Operating Earnings from Continuing Operations	26,633	28,696
Interest Income	(298)	(96)
Interest Expense	7,604	7,888
Earnings from Continuing Operations Before Income Taxes	19,327	20,904
Income Tax Expense	53,789	(463)
Earnings (Loss) from Continuing Operations Including Noncontrolling Interests	(34,462)	21,367
Earnings Attributable to Noncontrolling Interests	(353)	(239)
Earnings (Loss) from Continuing Operations Attributable to Esterline, Net of Tax	(34,815)	21,128
Loss from Discontinued Operations Attributable to Esterline, Net of Tax	(166)	(5,336)
Net Earnings (Loss) Attributable to Esterline	$ (34,981)	$ 15,792
Earnings (Loss) Per Share Attributable to Esterline - Basic:
Continuing operations	$ (1.16)	$ 0.71
Discontinued operations	(0.01)	(0.18)
Earnings (Loss) Per Share	(1.17)	0.53
Earnings (Loss) Per Share Attributable to Esterline - Diluted:
Continuing operations	(1.16)	0.71
Discontinued operations	(0.01)	(0.18)
Earnings (Loss) Per Share	$ (1.17)	$ 0.53
Net Earnings (Loss)	$ (34,981)	$ 15,792
Change in Fair Value of Derivative Financial Instruments	(560)	(6,841)
Income Tax Expense (Benefit)	(110)	(1,909)
Change in Fair Value of Derivative Financial Instruments, Net of Tax	(450)	(4,932)
Change in Pension and Post-Retirement Obligations	842	2,533
Income Tax Expense (Benefit)	297	992
Change in Pension and Post-Retirement Obligations, Net of Tax	545	1,541
Foreign Currency Translation Adjustment	6,354	(53,021)
Comprehensive Income (Loss)	$ (28,532)	$ (40,620)

XML

CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Dec. 29, 2017	Dec. 30, 2016
Cash Flows Provided (Used) by Operating Activities
Net earnings (loss) including noncontrolling interests	$ (34,628)	$ 16,031
Adjustments to reconcile net earnings (loss) including noncontrolling interests to net cash provided (used) by operating activities:
Depreciation and amortization	26,216	25,625
Deferred income taxes	4,456	(9,152)
Share-based compensation	3,998	4,171
Loss on disposal of fixed assets	2,007	0
Gain (loss) on assets held for sale	(89)	4,728
Working capital changes:
Accounts receivable	61,148	48,499
Inventories	(15,790)	(16,739)
Prepaid expenses	(3,427)	(2,075)
Other current assets	(590)	(876)
Accounts payable	(5,870)	(9,096)
Accrued liabilities	(21,652)	(11,388)
U.S. and foreign income taxes	5,241	(6,883)
Long-term U.S. income taxes payable	38,640	0
Other liabilities	(649)	1,361
Other, net	3,427	1,325
Net Cash Provided (Used) by Operating Activities	62,438	45,531
Cash Flows Provided (Used) by Investing Activities
Purchase of capital assets	(13,402)	(15,298)
Net Cash Provided (Used) by Investing Activities	(13,402)	(15,298)
Cash Flows Provided (Used) by Financing Activities
Proceeds provided by stock issuance under employee stock plans	1,171	10,729
Withholding taxes on restricted stock units vested	(227)	(863)
Shares repurchased	(20,445)	0
Repayment of long-term credit facilities	(5,000)	(10,000)
Repayment of long-term debt	(3,553)	(3,073)
Proceeds from issuance of long-term credit facilities	25,000	5,000
Net Cash Provided (Used) by Financing Activities	(3,054)	1,793
Effect of Foreign Exchange Rates on Cash and Cash Equivalents	1,064	(12,522)
Net Increase (Decrease) in Cash and Cash Equivalents	47,046	19,504
Cash and Cash Equivalents - Beginning of Year	307,826	258,520
Cash and Cash Equivalents - End of Period	354,872	278,024
Supplemental Cash Flow Information:
Cash paid for interest	10,478	10,745
Cash paid for taxes	$ 6,179	$ 13,775

XML

Basis of Presentation

3 Months Ended

Dec. 29, 2017

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Basis of Presentation

Note 1 – Basis of Presentation

The consolidated balance sheet as of December 29, 2017, the consolidated statement of operations and comprehensive income (loss) for the three-month periods ended December 29, 2017, and December 30, 2016, and the consolidated statement of cash flows for the three-month periods ended December 29, 2017, and December 30, 2016, are unaudited but, in the opinion of management, all of the necessary adjustments, consisting of normal recurring accruals, have been made to present fairly the financial statements referred to above in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X.  Accordingly, the above statements do not include all of the footnotes required for complete financial statements.  The results of operations and cash flows for the interim periods presented are not necessarily indicative of results that can be expected for the full year.

The notes to the consolidated financial statements in the Company’s Annual Report on Form 10-K for the fiscal year ended September 29, 2017, provide a summary of significant accounting policies and additional financial information that should be read in conjunction with this Form 10-Q.

The timing of the Company’s revenues is impacted by the purchasing patterns of customers and, as a result, revenues are not generated evenly throughout the year.  Moreover, the Company’s first fiscal quarter, October through December, includes significant holiday periods in both Europe and North America, resulting in fewer business days.

XML

Recent Accounting Pronouncements

3 Months Ended

Dec. 29, 2017

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Recent Accounting Pronouncements

Note 2 – Recent Accounting Pronouncements

In March 2017 the Financial Accounting Standards Board (FASB) issued new guidance on the presentation of the net periodic cost of postretirement benefit programs.  The new standard requires sponsors of defined benefit postretirement plans to present the non-service cost components of net periodic benefit cost separate from the service cost component on the income statement.  The new standard also requires that the non-service cost components of net periodic benefit cost no longer be capitalized within assets.  The Company is evaluating the effects the standard will have on the Company’s consolidated financial statements and related disclosures beyond the change in income statement presentation.  This new standard is effective for the Company in fiscal year 2019, with early adoption permitted.

In January 2017 the FASB issued new guidance regarding the goodwill impairment test.  The new guidance eliminates the Step 2 valuation test when evaluating goodwill for impairment.  The new guidance requires that an entity performs its annual or interim goodwill test by comparing the fair value of the reporting unit with its carrying amount.  An entity should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value.  The loss recognized should not exceed the total amount of goodwill allocated to that reporting unit.  The guidance is effective for the Company in fiscal year 2021, with early adoption permitted.  The standard was implemented in the first quarter of fiscal 2018.

In October 2016 the FASB issued new guidance regarding income taxes.  The new guidance will require the tax effects of intercompany transactions, other than sales of inventory, to be recognized currently, eliminating an exception under current Generally Accepted Accounting Principles (GAAP) in which the tax effects of intra-entity asset transfers are deferred until the transferred asset is sold to a third party or otherwise recovered through use.  The Company is evaluating the effect the updated standard will have on the Company’s consolidated financial statements and related disclosures.  The guidance will be effective for the company in fiscal year 2019, with early adoption permitted.

In August 2016 the FASB issued new guidance addressing how certain cash receipts and cash payments are presented and classified in the statement of cash flows.  The Company is evaluating the effect the updated standard will have on the Company’s consolidated financial statements and related disclosures.  The guidance will be effective for the Company in fiscal year 2019, with early adoption permitted.

In June 2016 the FASB issued a new standard on the measurement of credit losses, which will impact the Company’s measurement of trade receivables.  The new standard replaces the current incurred loss model with a forward-looking expected loss model that is likely to result in earlier recognition of losses.  The Company is evaluating the effect the updated standard will have on the Company’s consolidated financial statements and related disclosures.  The new standard is effective for the Company in 2021, with early adoption permitted, but not earlier than 2020.

In February 2016 the FASB issued a new lease accounting standard, which provides revised guidance on accounting for lease arrangements by both lessors and lessees.  The central requirement of the new standard is that lessees must recognize lease-related assets and liabilities for all leases with a term longer than 12 months.  The Company is evaluating the effect the standard will have on the Company’s consolidated financial statements and related disclosures.  The new standard is effective for the Company in fiscal year 2020, with early adoption permitted.

In July 2015, the FASB issued guidance which simplifies the subsequent measurement of inventory by requiring inventory to be measured at the lower of cost and net realizable value. Net realizable value is the estimated selling price of inventory in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation.  This new guidance was adopted in the first quarter of fiscal 2018, with no impact to the Company’s consolidated financial statements and related disclosures.

Revenue Recognition

In May 2014 the FASB issued a comprehensive new revenue recognition standard that effectively replaces all current guidance on the topic.  The guidance permits the use of either a retrospective or a cumulative effect transition method.

The Company has performed a review of the new guidance against the Company’s current accounting practices.  The Company has reviewed a representative sample of contracts and other agreements with customers and evaluated the provisions contained within these agreements compared with the amended guidance.

This amended guidance is expected to change the revenue recognition practices for a number of revenue streams across our businesses; the most significant will be for certain U.S. government contracts and certain other contracts that meet one or more of the mandatory criteria, which will move revenue recognition from a “point-in-time” basis to an “over-time” basis.  The on-going effect of recording revenue on an “over-time” basis is not expected to be materially different than under the historical guidance.

The amended guidance is also expected to change the recognition of certain development costs that are contractually guaranteed for reimbursement by our customers.  Contractually guaranteed reimbursements for development efforts are currently recognized as the development activities are performed.  Under the amended guidance, the contractually guaranteed reimbursement specific to the development effort will be deferred as a contract liability and recognized as revenue when future products are delivered to the customer in cases where the Company does not transfer all intellectual property rights related to the development effort to the customer or does not have an enforceable right to payment for performance completed to date.  The costs associated with development effort under an arrangement with contractually guaranteed reimbursement will also be deferred, up to the amount reimbursed, and recognized through cost of goods sold as products are delivered to the customer.  The on-going effect of deferring contractually guaranteed reimbursements and the related costs until products are delivered to the customer is not expected to be materially different than under the historical guidance.

The new standard also significantly enhances required disclosures regarding revenue and related assets and liabilities.  The Company is in the process of implementing changes to business processes, systems and internal controls required to adopt the new accounting standard.

The updated standard becomes effective for the Company in the first quarter of fiscal 2019, with early adoption permitted.  The Company expects to apply the standard using the cumulative effect transition basis, with a cumulative effect adjustment recognized at the beginning of fiscal year 2019.

XML

Earnings Per Share and Shareholders Equity

3 Months Ended

Dec. 29, 2017

Earnings Per Share [Abstract]

Earnings Per Share and Shareholders Equity

Note 3 – Earnings Per Share and Shareholders’ Equity

Basic earnings per share is computed on the basis of the weighted average number of shares outstanding during the year.  Diluted earnings per share includes the dilutive effect of stock options, restricted stock units and share units related to the Company’s performance share plan to the extent that performance share plan objectives are met.  Common shares issuable from stock options excluded from the calculation of diluted earnings per share because they were anti-dilutive were 809,875 in the three-month period ending December 30, 2016.  Shares used for calculating earnings per share are disclosed in the following table:

In Thousands	Three Months Ended
	December 29,		December 30,
	2017		2016
Shares used for basic earnings per share		29,903		29,547
Shares used for diluted earnings per share		29,903		29,831

The authorized capital stock of the Company consists of 25,000 shares of preferred stock ($100 par value), 475,000 shares of serial preferred stock ($1.00 par value), each issuable in series, and 60,000,000 shares of common stock ($.20 par value).  As of December 29, 2017, and September 29, 2017, there were no shares of preferred stock or serial preferred stock outstanding.

On June 19, 2014, the Company’s Board of Directors approved a $200 million share repurchase program.  In March 2015, the Company’s Board of Directors approved an additional $200 million for the share repurchase program.  Under the program, the Company is authorized to repurchase up to $400 million of outstanding shares of common stock from time to time, depending on market conditions, share price and other factors.  Repurchases may be made in the open market or through private transactions, in accordance with SEC requirements.  The Company may enter into a Rule 10(b)5-1 plan designed to facilitate the repurchase of all or a portion of the repurchase amount.  The program does not require the Company to acquire a specific number of shares.  Common stock repurchased can be reissued, and accordingly, the Company accounts for repurchased stock under the cost method of accounting.

During the three months ended December 29, 2017, the Company repurchased 287,500 shares under this program at an average price paid per share of $71.11, for an aggregate purchase price of $20.4 million.  There were no shares repurchased during the three months ended December 30, 2016.  Subsequent to December 29, 2017, we repurchased 313,900 shares under this program at an average price paid per share of $72.25, for an aggregate purchase price of $23.0 million through March 30, 2018.  Since the program began, the Company has repurchased 3,737,327 shares for an aggregate purchase price of $352.0 million, with $48.0 million in shares remaining available for repurchase in the future.

Changes in issued and outstanding common shares are summarized as follows:

	Three Months Ended			Year Ended
	December 29,			September 29,
	2017			2017
Shares Issued:
Balance, beginning of year		33,117,473			32,564,252
Shares issued under share-based compensation plans		27,693			553,221
Balance, end of current period		33,145,166			33,117,473
Treasury Stock:
Balance, beginning of year		(3,135,927	)		(3,135,927	)
Shares purchased		(287,500	)		-
Balance, end of current period		(3,423,427	)		(3,135,927	)
Shares outstanding, end of period		29,721,739			29,981,546

The components of Accumulated Other Comprehensive Income (Loss):

In Thousands	December 29,			September 29,
	2017			2017
Unrealized gain on derivative contracts	$	12,909		$	13,469
Tax effect		(3,782	)		(3,892	)
		9,127			9,577
Pension and post-retirement obligations		(80,940	)		(81,782	)
Tax effect		27,659			27,956
		(53,281	)		(53,826	)
Foreign currency translation adjustment		(216,267	)		(222,621	)
Accumulated other comprehensive income (loss)	$	(260,421	)	$	(266,870	)

XML

Retirement Benefits

3 Months Ended

Dec. 29, 2017

Compensation And Retirement Disclosure [Abstract]

Retirement Benefits

Note 4 – Retirement Benefits

The Company’s pension plans principally include a U.S. pension plan maintained by Esterline and a non-U.S. plan maintained by CMC Electronics, Inc. (CMC).  The Company also sponsors a number of other non-U.S. defined benefit pension plans, primarily in Belgium, France and Germany.  Components of periodic pension cost consisted of the following:

In Thousands	Three Months Ended
	December 29,			December 30,
	2017			2016
Components of Net Periodic Cost
Service cost	$	3,374		$	3,357
Interest cost		4,106			3,721
Expected return on plan assets		(6,808	)		(6,265	)
Amortization of prior service cost		126			114
Amortization of actuarial (gain) loss		797			1,763
Net periodic cost (benefit)	$	1,595		$	2,690

The Company amortizes prior service cost and actuarial gains and losses from accumulated other comprehensive income to expense over the remaining service period.

XML

Fair Value Measurements

3 Months Ended

Dec. 29, 2017

Fair Value Disclosures [Abstract]

Fair Value Measurements

Note 5 – Fair Value Measurements

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.  A fair value hierarchy has been established that prioritizes the inputs to valuation techniques used to measure fair value.  An asset’s or liability’s level within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement.  The hierarchy of fair value measurements is described below:

Level 1 – Valuations are based on quoted prices that the Company has the ability to obtain in actively traded markets for identical assets and liabilities.  Since valuations are based on quoted prices that are readily and regularly available in an active market or exchange traded market, a valuation of these instruments does not require a significant degree of judgment.

Level 2 – Valuations are based on quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market.

Level 3 – Valuations are based on model-based techniques for which some or all of the assumptions are not observable and therefore obtained from indirect market information that is significant to the overall fair value measurement and which require a significant degree of management judgment.

The following table sets forth the Company’s financial assets and liabilities that were measured at fair value on a recurring basis by level within the fair value hierarchy at December 29, 2017, and September 29, 2017.

In Thousands	Level 2
	December 29,		September 29,
	2017		2017
Assets:
Derivative contracts designated as hedging instruments	$	13,273	$	13,932
Derivative contracts not designated as hedging instruments		893		284
Embedded derivatives		681		746
Liabilities:
Derivative contracts designated as hedging instruments	$	364	$	464
Derivative contracts not designated as hedging instruments		1,445		2,440
Embedded derivatives		1,792		2,239

In Thousands	Level 3
	December 29,		September 29,
	2017		2017
Assets:
Estimated value of assets held for sale	$	16,844	$	19,835
Liabilities:
Estimated value of liabilities held for sale	$	5,189	$	8,908

The Company’s embedded derivatives are the result of entering into sales or purchase contracts that are denominated in a currency other than the Company’s functional currency or the supplier’s or customer’s functional currency.  The fair value is determined by calculating the difference between quoted exchange rates at the time the contract was entered into and the period-end exchange rate.  These contracts are categorized as Level 2 in the fair value hierarchy.

The Company’s derivative contracts consist of foreign currency exchange contracts and, from time to time, interest rate swap agreements.  These derivative contracts are over the counter, and their fair value is determined using modeling techniques that include market inputs such as interest rates, yield curves, and currency exchange rates.  These contracts are categorized as Level 2 in the fair value hierarchy.

The Company’s board of directors previously approved the plan to sell certain non-core business units.  Based upon the estimated fair values, the Company adjusted the carrying value of the assets and liabilities of the businesses to fair value.  Principle assumptions used in measuring the estimated value of assets and liabilities held for sale included estimated selling price of the discontinued business, discount rates, industry growth rates, and pricing of comparable transactions in the market.  The valuations are categorized as Level 3 in the fair value hierarchy.

XML

Derivative Financial Instruments

3 Months Ended

Dec. 29, 2017

Derivative Instruments And Hedging Activities Disclosure [Abstract]

Derivative Financial Instruments

Note 6 – Derivative Financial Instruments

The Company uses derivative financial instruments in the form of foreign currency forward exchange contracts and interest rate swap contracts for the purpose of minimizing exposure to changes in foreign currency exchange rates on business transactions and interest rates, respectively.  The Company’s policy is to execute such instruments with banks the Company believes to be creditworthy and not to enter into derivative financial instruments for speculative purposes.  These derivative financial instruments do not subject the Company to undue risk, as gains and losses on these instruments generally offset gains and losses on the underlying assets, liabilities, or anticipated transactions that are being hedged.

All derivative financial instruments are recorded at fair value in the Consolidated Balance Sheet.  For a derivative that has not been designated as an accounting hedge, the change in the fair value is recognized immediately through earnings.  For a derivative that has been designated as an accounting hedge of an existing asset or liability (a fair value hedge), the change in the fair value of both the derivative and underlying asset or liability is recognized immediately through earnings.  For a derivative designated as an accounting hedge of an anticipated transaction (a cash flow hedge), the change in the fair value is recorded on the Consolidated Balance Sheet in Accumulated Other Comprehensive Income (AOCI) to the extent the derivative is effective in mitigating the exposure related to the anticipated transaction.  The change in the fair value related to the ineffective portion of the hedge, if any, is immediately recognized in earnings.  The amount recorded within AOCI is reclassified into earnings in the same period during which the underlying hedged transaction affects earnings.

The fair value of derivative instruments is presented on a gross basis, as the Company does not have any derivative contracts which are subject to master netting arrangements.  The Company did not have any hedges with credit-risk-related contingent features or that required the posting of collateral as of December 29, 2017, and September 29, 2017.  The cash flows from derivative contracts are recorded in operating activities in the Consolidated Statement of Cash Flows.

Foreign Currency Forward Exchange Contracts

The Company transacts business in various foreign currencies, which subjects the Company’s cash flows and earnings to exposure related to changes in foreign currency exchange rates.  These exposures arise primarily from purchases or sales of products and services from third parties.  Foreign currency forward exchange contracts provide for the purchase or sale of foreign currencies at specified future dates at specified exchange rates, and are used to offset changes in the fair value of certain assets or liabilities or forecasted cash flows resulting from transactions denominated in foreign currencies.  At December 29, 2017, and September 29, 2017, the Company had outstanding foreign currency forward exchange contracts principally to sell U.S. dollars with notional amounts of $428.8 million and $406.9 million, respectively.  The notional value of our foreign currency forward contracts includes $69.2 million related to the hedge of a portion of our net monetary assets, including the embedded derivatives in our backlog.  These notional values consist primarily of contracts for the British pound sterling, Canadian dollar, and European euro and are stated in U.S. dollar equivalents at spot exchange rates at the respective dates.

Interest Rate Swaps

The Company manages its exposure to interest rate risk by maintaining an appropriate mix of fixed and variable rate debt, which over time should moderate the costs of debt financing.  When considered necessary, the Company may use financial instruments in the form of interest rate swaps to help meet this objective.

Embedded Derivative Instruments

The Company’s embedded derivatives are the result of entering into sales or purchase contracts that are denominated in a currency other than the Company’s functional currency or the supplier’s or customer’s functional currency.

Net Investment Hedge

In April 2015 the Company issued €330.0 million in 3.625% Senior Notes due April 2023 (2023 Notes) and requiring semi-annual interest payments in April and October each year until maturity.  The Company designated the 2023 Notes and accrued interest as a hedge of the investment of certain foreign business units.  The foreign currency gain or loss that is effective as a hedge is reported as a component of accumulated other comprehensive income (loss) in shareholders’ equity.  To the extent that this hedge is ineffective, the foreign currency gain or loss is recorded in earnings.  There was no ineffectiveness of the hedge since inception.

Fair Value of Derivative Instruments

Fair value of derivative instruments in the Consolidated Balance Sheet at December 29, 2017, and September 29, 2017, consisted of:

In Thousands		Fair Value
		December 29,		September 29,
	Classification	2017		2017
Foreign Currency Forward Exchange Contracts:
	Other current assets	$	11,708	$	11,433
	Other assets		2,458		2,783
	Accrued liabilities		1,653		2,506
	Other liabilities		156		398
Embedded Derivative Instruments:
	Other current assets	$	534	$	604
	Other assets		147		142
	Accrued liabilities		1,306		1,657
	Other liabilities		486		582

The effect of derivative instruments on the Consolidated Statement of Operations and Comprehensive Income (Loss) for the three-month periods ended December 29, 2017, and December 30, 2016, consisted of:

Fair Value Hedges and Embedded Derivatives

The Company recognized the following gains (losses) on contracts designated as fair value hedges and embedded derivatives:

In Thousands	Three Months Ended
Gain (Loss)	December 29,			December 30,
	2017			2016
Fair Value Hedges:
Recognized in cost of sales	$	(378	)	$	(933	)
Recognized in selling, general & administrative		(323	)		(768	)
Embedded derivatives:
Recognized in sales	$	345		$	253

Cash Flow Hedges

The Company recognized the following gains (losses) on contracts designated as cash flow hedges:

In Thousands	Three Months Ended
Gain (Loss)	December 29,			December 30,
	2017			2016
Foreign currency forward exchange contracts:
Recognized in AOCI (effective portion)	$	(2,493	)	$	(2,416	)
Reclassified from AOCI into sales		1,933			(4,425	)

Net Investment Hedges

The Company recognized the following gains (losses) on contracts designated as net investment hedges:

In Thousands	Three Months Ended
Gain (Loss)	December 29,			December 30,
	2017			2016
2023 Notes and Accrued Interest:
Recognized in AOCI	$	(6,297	)	$	23,913

During the first quarter of fiscal 2018 and 2017, the Company recorded a gain of $1.5 million and a loss of $0.9 million, respectively, on foreign currency forward exchange contracts that have not been designated as accounting hedges.  These foreign currency exchange gains and losses are included in selling, general and administrative expense.

There was no significant impact to the Company’s earnings related to the ineffective portion of any hedging instruments during the first quarter of fiscal 2018 and 2017.  In addition, there was no significant impact to the Company’s earnings when a hedged firm commitment no longer qualified as a fair value hedge or when a hedged forecasted transaction no longer qualified as a cash flow hedge during the first quarter of fiscal 2018 and 2017.

Amounts included in AOCI are reclassified into earnings when the hedged transaction settles.  The Company expects to reclassify approximately $10.9 million of net gain into earnings over the next 12 months.  The maximum duration of the Company’s foreign currency cash flow hedge contracts at December 29, 2017, was 24 months.

XML

Insurance Recovery

3 Months Ended

Dec. 29, 2017

Insurance [Abstract]

Insurance Recovery

Note 7 – Insurance Recovery

In the first quarter of fiscal 2017, the Company received a $2.6 million insurance recovery resulting from an energetic incident at one of the Company’s countermeasure operations, which occurred in the first quarter of fiscal 2016.  The Company also received a $5.0 million insurance recovery in the fourth quarter of fiscal 2016 and $5.2 million in the second quarter of fiscal 2017 related to the energetic incident.  Management does not anticipate additional insurance recoveries arising from this matter in fiscal 2018.  The insurance recovery is reported as a separate line item on the Consolidated Statement of Operations and Comprehensive Income (Loss) and is included in Advanced Materials segment earnings.

XML

License Fee Income

3 Months Ended

Dec. 29, 2017

Revenues [Abstract]

License Fee Income

Note 8 – License Fee Income

On December 22, 2017, the Company granted an exclusive license to a third party to manufacture, repair and sell certain legacy control devices for $3.0 million.  Additionally, the Company sold certain inventory and manufacturing equipment to the licensee for $1.0 million.  The Company will be paid a 15% royalty on future sales of the licensed product.  The license fee is reported as a separate line item on the Consolidated Statement of Operations and Comprehensive Income (Loss) and is included in Avionics & Controls segment earnings.

XML

Income Taxes

3 Months Ended

Dec. 29, 2017

Income Tax Disclosure [Abstract]

Income Taxes

Note 9 – Income Taxes

The Tax Cuts and Jobs Act (the Act) was enacted on December 22, 2017.  The Act reduces the U.S. federal corporate tax rate from 35% to 21%, requires companies to pay a one-time transition tax on earnings of certain foreign subsidiaries that were previously tax deferred and creates new taxes on certain foreign sourced earnings.  

The SEC recognized that a company’s review of certain income tax effects of the Act may be incomplete at the time financial statements are issued.  Accordingly, the SEC issued Staff Accounting Bulletin 118, which provides that if a company does not have the necessary information available for certain effects of the Act, the Company may record provisional numbers and adjust those amounts during the measurement period not to extend beyond one year.

At December 29, 2017, the Company had not completed the accounting for the tax effects of enactment of the Act; however, in certain cases, as described below, the Company made a reasonable estimate of the effects on its existing deferred tax balances and the one-time transition tax.  In other cases, the Company was not able to make a reasonable estimate and continued to account for those items based on its existing accounting under ASC 740, Income Taxes, and the provisions of the tax laws that were in effect immediately prior to enactment.  For the items for which the Company was able to determine a reasonable estimate, the Company recognized a provisional amount of $48.6 million, which is included as a component of income tax expense from continuing operations.  In all cases, the Company will continue to make and refine the calculations as additional analysis is completed.  In addition, the estimates may also be affected as the Company gains a more thorough understanding of the tax law.

Provisional Amounts

U.S. Deferred Tax Assets and Liabilities

The Company remeasured certain deferred tax assets and liabilities based on the rates at which they are expected to reverse in the future, which is generally 21%.  However, the Company is still analyzing certain aspects of the Act and refining its calculations, including evaluation of limits on employee remuneration, which could affect the measurement of these balances or potentially give rise to new deferred tax amounts.  The provisional amount recorded related to the remeasurement of the deferred tax balance was $6.6 million.

Foreign Tax Effects

The one-time transition tax is based on the Company’s total post-1986 earnings and profits (E&P) that the Company previously deferred from U.S. income taxes.  The Company recorded a provisional amount for its one-time transition tax liability resulting in an increase in income tax expense of $42.0 million.  The Company is still analyzing certain aspects of the Act and refining its calculations, which could potentially affect the measurement of these amounts, including the benefit attributable to foreign tax credits and related elections.  Further, the transition tax is based in part on the amount of those earnings held in cash and other specified assets.  This amount may change when the Company finalizes the calculations of post-1986 foreign E&P previously deferred from U.S. taxation and finalizes the amounts of cash or other specified assets.  The Act sets certain limits that may restrict the Company’s use of any foreign tax credits generated from the one-time transaction tax.  As of the date of this report, management was not able to (1) determine a reasonable estimate of the tax liability for the Company’s remaining outside basis; (2) complete an analysis of the Global Intangible Low Taxed Income (GILTI); (3) determine the accounting for GILTI because ASC 740 is not clear whether GILTI will require the recording of deferred income tax expense; and (4) evaluate how the Act will impact the Company’s existing APB 23 position to indefinitely reinvest unremitted foreign earnings.  This could result in a material adjustment to the provisional income tax expense recorded in the first quarter of fiscal 2018.

The income tax rate for the first quarter of fiscal 2018 was 26.9% before the effect of the provisional taxes due to the Act and was 278.3% after the effect of the provisional taxes due to the Act.  The prior-year period was a benefit of 2.2%.  The Company conducts business in numerous tax jurisdictions, principally in the U.S., Canada, U.K. and France.  As a result, the Company’s income tax rate for the first fiscal quarter of 2018 reflects the estimated annual global effective tax rate, excluding discrete items, applied to year-to-date pre-tax earnings.

The following table summarizes the income tax rate for the first quarter of fiscal 2018 excluding and including the provisional taxes due to the Act.

In Thousands	Three Months Ended
	December 29, 2017
	Excluding			Including
Earnings from Continuing Operations Before Income Taxes	$	19,327		$	19,327
Income Tax Expense		5,573			5,573
Change in Tax Rate Due to the Act		(368	)		(368	)
Provisional Taxes Due to the Act		-			48,584
Total Income Tax Expense		5,205			53,789
Tax Rate		26.9	%		278.3	%

The income tax rate for the first quarter of fiscal 2018 reflected a blended U.S. tax rate of 24.5%, which is based upon an income tax rate of 35% for the Company’s first quarter of fiscal 2018 and 21% for the balance of the year ending September 28, 2018.

The 2.2% income tax rate in the first quarter of fiscal 2017 reflected the following items:  First, a reduction of the income tax rate in France for fiscal year 2020, which resulted in a reduction in the Company’s net deferred income tax liabilities of $3.8 million.  Second, $1.6 million of discrete tax benefits was recorded, primarily related to a valuation allowance release due to an expected taxable gain from a foreign income tax law change.  Third, the early adoption of the accounting standard update for employee share-based payment awards resulted in a $0.7 million tax benefit.

By the end of fiscal 2018, it is reasonably possible that approximately $1.4 million of tax benefits that are currently unrecognized could be recognized as a result of settlement of examinations and/or the expiration of applicable statutes of limitations.  The Company recognizes interest related to unrecognized tax benefits in income tax expense.

XML

Debt

3 Months Ended

Dec. 29, 2017

Debt Disclosure [Abstract]

Debt

Note 10 – Debt

Long-term debt at December 29, 2017 and September 29, 2017, consisted of the following:

In Thousands	December 29,			September 29,
	2017			2017
U.S. credit facility	$	70,000		$	50,000
U.S. Term Loan, due April 2020		221,875			225,000
3.625% Senior Notes, due April 2023		396,099			389,862
Government refundable advances		45,464			45,549
Obligation under capital leases		70,693			71,091
Debt issuance costs		(4,415	)		(4,654	)
		799,716			776,848
Less current maturities		17,429			17,424
Carrying amount of long-term debt	$	782,287		$	759,424

U.S. Credit Facility

On April 9, 2015, the Company amended its secured credit facility to extend the maturity to April 9, 2020, increase the revolving credit facility to $500 million, and provide for a delayed-draw term loan facility of $250 million.  The Company recorded $2.3 million in debt issuance costs.  The credit facility is secured by substantially all the Company’s assets, and interest is based on standard inter-bank offering rates.  The interest rate ranges from LIBOR plus 1.25% to LIBOR plus 2.00% depending on leverage ratios at the time the funds are drawn.  At December 29, 2017, the Company had $70.0 million outstanding under the secured credit facility at an interest rate of LIBOR plus 1.50%, which was 2.82%. On February 13, 2018, the Company obtained a waiver and consent from the required lenders under the Company’s U.S. credit facilities of the financial reporting breaches resulting from the Restatement described in Note 2 of Company’s fiscal 2017 Form 10-K/A.

U.S. Term Loan, due April 2020

On August 3, 2015, the Company borrowed $250 million under the amended secured credit facility (U.S. Term Loan, due 2020).  The interest rate on the U.S. Term Loan, due 2020, ranges from LIBOR plus 1.25% to LIBOR plus 2.00%.  At December 29, 2017, the interest rate was LIBOR plus 1.50%, or 2.85%.  The loan amortizes at 1.25% of the original principal balance quarterly through March 2020, with the remaining balance due in April 2020.

3.625% Senior Notes, due April 2023

In April 2015 TA Mfg. Limited, a wholly owned subsidiary of the Company, issued €330.0 million in 3.625% Notes, due 2023 requiring semi-annual interest payments in April and October of each year until maturity.  The net proceeds from the sale of the notes, after deducting $5.9 million of debt issuance costs, were $350.8 million.  The 2023 Notes are general unsecured senior obligations of the Company.  The 2023 Notes are unconditionally guaranteed on a senior basis by the Company and certain subsidiaries of the Company that are guarantors under the Company’s existing secured credit facility.  The 2023 Notes are subject to redemption at the option of the Company at any time prior to April 15, 2018, at a price equal to 100% of the principal amount, plus any accrued interest to the date of redemption and a make-whole provision.  The Company may also redeem up to 35% of the 2023 Notes before April 15, 2018, with the net cash proceeds from equity offerings.  The 2023 Notes are also subject to redemption at the option of the Company, in whole or in part, on or after April 15, 2018, at redemption prices starting at 102.719% of the principal amount plus accrued interest during the period beginning April 15, 2018, and declining annually to 100% of principal and accrued interest on or after April 15, 2021.

Based on quoted market prices, the fair value of the Company’s 2023 Notes was $406.1 million and $403.2 million as of December 29, 2017, and September 29, 2017, respectively.  The carrying amount of the secured credit facility and the U.S. Term Loan, due 2020, approximate fair value.  The estimate of fair value for the 2023 Notes is based on Level 2 inputs as defined in the fair value hierarchy described in Note 5.

Government Refundable Advances

Government refundable advances consist of payments received from the Canadian government to assist in research and development related to commercial aviation.  The requirement to repay this advance is solely based on year-over-year commercial aviation revenue growth at CMC beginning in 2014.  Imputed interest on the advance was 2.52% at December 29, 2017.  The debt recognized was $45.5 million at December 29, 2017, and September 29, 2017.

Obligation Under Capital Lease

The Company leases building and equipment under capital leases.  The present value of the minimum capital lease payments, net of the current portion, totaled $68.6 million and $69.0 million as of December 29, 2017, and September 29, 2017, respectively.

XML

Commitments and Contingencies

3 Months Ended

Dec. 29, 2017

Commitments And Contingencies Disclosure [Abstract]

Commitments and Contingencies

Note 11 – Commitments and Contingencies

The Company is party to various lawsuits and claims, both as a plaintiff and defendant, and has contingent liabilities arising from the conduct of business, none of which, in the opinion of management, is expected to have a material effect on the Company’s financial position or results of operations.  The Company believes that it has made appropriate and adequate provisions for contingent liabilities.

On March 5, 2014, the Company entered into a Consent Agreement with the U.S. Department of State’s Directorate of Defense Trade Controls Office of Defense Trade Controls Compliance (DTCC) to resolve alleged International Traffic in Arms Regulations (ITAR) civil violations.  Among other things, the Consent Agreement required the Company to pay a $20 million penalty, of which $10 million was suspended and eligible for offset credit.  In fiscal 2016, the DTCC approved costs the Company incurred to implement compliance measures to fully offset the $10 million suspended payment.  The Consent Agreement was closed in fiscal 2017.

XML

Employee Stock Plans

3 Months Ended

Dec. 29, 2017

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Employee Stock Plans

Note 12 – Employee Stock Plans

As of December 29, 2017, the Company had three share-based compensation plans, which are described below.  The compensation cost that has been charged against income for those plans was $4.0 million and $4.2 million for the first three months of fiscal 2018 and 2017, respectively.  During the first three months of fiscal 2018 and 2017, the Company issued 27,693 and 237,547 shares, respectively, under its share-based compensation plans.

Employee Stock Purchase Plan (ESPP)

The ESPP is a “safe-harbor” designed plan whereby shares are purchased by participants at a discount of 5% of the market value on the purchase date and, therefore, compensation cost is not recorded.

Employee Sharesave Scheme

The Company offers shares under its employee sharesave scheme for U.K. employees.  This plan allows participants the option to purchase shares at a 5% discount of the market price of the stock as of the beginning of the offering period.  The term of these options is three years.  The sharesave scheme is not a “safe-harbor” design, and therefore, compensation cost is recognized on this plan.  Under the sharesave scheme, option exercise prices are equal to the fair market value of the Company’s common stock on the date of grant.  There were no grants in the three-month periods ended December 29, 2017, and December 30, 2016.

Equity Incentive Plan

Under the equity incentive plan, option exercise prices are equal to the fair market value of the Company’s common stock on the date of grant.  The Company granted 197,700 and 231,100 options to purchase shares in the three-month periods ended December 29, 2017, and December 30, 2016, respectively.  The weighted-average grant date fair value of options granted during the three-month periods ended December 29, 2017, and December 30, 2016, was $31.20 and $32.55 per share, respectively.

The fair value of each option granted by the Company was estimated using a Black-Scholes pricing model, which uses the assumptions noted in the following table.  The Company uses historical data to estimate volatility of the Company’s common stock and option exercise and employee termination assumptions.  The risk-free rate for the contractual life of the option is based on the U.S. Treasury zero coupon issues in effect at the time of the grant.

	Three Months Ended
	December 29,	December 30,
	2017	2016
Volatility	34.32%	34.97 - 35.42%
Risk-free interest rate	2.15 - 2.47%	1.98 - 2.51%
Expected life (years)	5 - 9	5 - 9
Dividends	0	0

The Company granted 33,600 and 36,700 restricted stock units in the three-month periods ended December 29, 2017, and December 30, 2016, respectively.  The weighted-average grant date fair value of restricted stock units granted during the three-month periods ended December 29, 2017, and December 30, 2016, was $91.79 and $76.70 per share, respectively.  The fair value of each restricted stock unit granted by the Company is equal to the fair market value of the Company’s common stock on the date of grant.

The Company granted 33,700 and 42,100 performance share plan (PSP) shares in the three-month periods ended December 29, 2017, and December 30, 2016, respectively.  PSP shares will be paid out in shares of Esterline common stock at the end of the three year performance period.  The PSP shares granted in each period equaled the number of shares participants would receive if the Company achieves target performance over the relevant period.  The actual number of shares that will be paid out upon completion of the performance period is based on actual performance and may range from 0% to 300% of the target number of shares.

XML

Discontinued Operations

3 Months Ended

Dec. 29, 2017

Discontinued Operations And Disposal Groups [Abstract]

Discontinued Operations

Note 13 – Discontinued Operations

The Company’s Board of Directors previously approved the plan to sell certain non-core business units including Wallop Defence Systems, Ltd. (Wallop), a manufacturer of flare countermeasure devices; a small distribution business; and a small manufacturing business.

On May 4, 2016, the Company sold certain assets of Wallop for 2.5 million British pounds and deferred consideration up to a maximum payment of 9 million British pounds.  In the definitive purchase and sale agreement for the sale of these assets, the Company provided standard representations and warranties as well as indemnification to the buyer of the Wallop operation.  The Company is obligated to indemnify the buyer for certain losses of up to 5.0 million British pounds, if, among other things, the Company breaches the representations and warranties.  In the first quarter of fiscal 2018, the Company received notification of a claim from the buyer of the Wallop operation alleging breaches of representations and warranties primarily associated with defective products and late product deliveries.  Although a loss is possible, the amount of any loss related to this claim cannot be estimated at this time.  The Company does not expect the possible loss to have a material effect on the Company’s financial position.  The deferred consideration is payable based upon receipt of acceptable orders during a three-year period ending May 3, 2019, and is equal to the amount of the acceptable order times a specified percentage ranging from 26.5% to 31%.  The earn-out payment is estimated to be 4.1 million British pounds, or $5.5 million, at December 29, 2017.  In December 2017 the buyer notified the Company that 1.3 million British pounds, or $1.8 million, of deferred consideration had been earned.

On March 28, 2017, the Company sold a small manufacturing business for $0.6 million and a note receivable of $2.4 million, resulting in a gain on sale of the business of $0.8 million.  The note receivable is due March 28, 2021, with an interest rate of 2.05%.

The Company incurred a $0.2 million loss from discontinued operations in the first quarter of fiscal 2018 compared to a $5.3 million loss from discontinued operations in the first quarter of fiscal 2017.

The operating results of the discontinued operations for the three-month period ended December 29, 2017, consisted of the following:

In Thousands	Avionics &			Sensors &		Advanced
	Controls			Systems		Materials			Other		Total
Net Sales	$	-		$	-	$	-		$	-	$	-
Operating earnings (loss)		14			-		(283	)		-		(269	)
Tax expense (benefit)		23			-		(126	)		-		(103	)
Income (loss) from discontinued    operations	$	(9	)	$	-	$	(157	)	$	-	$	(166	)
Included in Operating Earnings (Loss):
Gain (loss) on net assets    held for sale	$	(51	)	$	-	$	140		$	-	$	89

The operating results of the discontinued operations for the three-month period ended December 30, 2016, consisted of the following:

In Thousands	Avionics &			Sensors &		Advanced
	Controls			Systems		Materials			Other			Total
Net Sales	$	2,696		$	-	$	-		$	-		$	2,696
Operating earnings (loss)		(871	)		895		(5,347	)		(604	)		(5,927	)
Tax expense (benefit)		(239	)		-		(141	)		(211	)		(591	)
Income (loss) from discontinued    operations	$	(632	)	$	895	$	(5,206	)	$	(393	)	$	(5,336	)
Included in Operating Earnings (Loss):
Gain (loss) on net assets    held for sale	$	(140	)	$	-	$	(4,588	)	$	-		$	(4,728	)

Assets and Liabilities Held for Sale within the Consolidated Balance Sheet at December 29, 2017, are comprised of the following:

In Thousands	Avionics &		Sensors &		Advanced
	Controls		Systems		Materials		Total
Other current assets	$	-	$	-	$	2,834	$	2,834
Current Assets of Businesses Held for Sale		-		-		2,834		2,834
Net property, plant and equipment		5,262		-		-		5,262
Other assets		-		-		8,748		8,748
Non-Current Assets of Businesses Held for Sale		5,262		-		8,748		14,010
Accounts payable		-		-		54		54
Accrued liabilities		-		-		2,063		2,063
Current Liabilities of Businesses Held for Sale		-		-		2,117		2,117
Deferred income tax liabilities		-		-		2,752		2,752
Other liabilities		-		-		320		320
Non-Current Liabilities of Businesses Held for Sale		-		-		3,072		3,072
Net Assets of Businesses Held for Sale	$	5,262	$	-	$	6,393	$	11,655

Assets and Liabilities Held for Sale within the Consolidated Balance Sheet at September 29, 2017, were comprised of the following:

In Thousands	Avionics &		Sensors &		Advanced
	Controls		Systems		Materials		Total
Other current assets	$	-	$	-	$	6,501	$	6,501
Current Assets of Businesses Held for Sale		-		-		6,501		6,501
Net property, plant and equipment		5,262		-		-		5,262
Other assets		-		-		8,072		8,072
Non-Current Assets of Businesses Held for Sale		5,262		-		8,072		13,334
Accounts payable		-		-		138		138
Accrued liabilities		-		-		7,046		7,046
Current Liabilities of Businesses Held for Sale		-		-		7,184		7,184
Deferred income tax liabilities		-		-		1,404		1,404
Other liabilities		-		-		320		320
Non-Current Liabilities of Businesses Held for Sale		-		-		1,724		1,724
Net Assets of Businesses Held for Sale	$	5,262	$	-	$	5,665	$	10,927

XML

Business Segment Information

3 Months Ended

Dec. 29, 2017

Segment Reporting [Abstract]

Business Segment Information

Note 14 – Business Segment Information

Business segment information for continuing operations includes the segments of Avionics & Controls, Sensors & Systems and Advanced Materials.

In Thousands	Three Months Ended
	December 29,			December 30,
	2017			2016
Sales
Avionics & Controls	$	202,703		$	192,682
Sensors & Systems		175,468			167,756
Advanced Materials		103,874			97,978
	$	482,045		$	458,416
Earnings from Continuing Operations Before Income Taxes
Avionics & Controls	$	20,385		$	17,917
Sensors & Systems		11,713			18,143
Advanced Materials		14,583			9,880
Segment Earnings		46,681			45,940
Corporate expense		(20,048	)		(17,244	)
Interest income		298			96
Interest expense		(7,604	)		(7,888	)
	$	19,327		$	20,904

XML

Subsequent Event

3 Months Ended

Dec. 29, 2017

Subsequent Events [Abstract]

Subsequent Event

Note 15 – Subsequent Event

The Board of Directors approved the sale of the Company’s elastomer business based in Brea, California known as the Kirkhill business in March 2018.  On March 15, 2018, the Company sold the assets and certain liabilities of this business to TransDigm, Inc. for $50 million, before a working capital adjustment to be determined when the closing balance sheet of the business is finalized.  The Company expects to record a loss on sale ranging from $5 million to $7 million.

XML

Recent Accounting Pronouncements (Policies)

3 Months Ended

Dec. 29, 2017

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Recent Accounting Pronouncements

In March 2017 the Financial Accounting Standards Board (FASB) issued new guidance on the presentation of the net periodic cost of postretirement benefit programs.  The new standard requires sponsors of defined benefit postretirement plans to present the non-service cost components of net periodic benefit cost separate from the service cost component on the income statement.  The new standard also requires that the non-service cost components of net periodic benefit cost no longer be capitalized within assets.  The Company is evaluating the effects the standard will have on the Company’s consolidated financial statements and related disclosures beyond the change in income statement presentation.  This new standard is effective for the Company in fiscal year 2019, with early adoption permitted.

In January 2017 the FASB issued new guidance regarding the goodwill impairment test.  The new guidance eliminates the Step 2 valuation test when evaluating goodwill for impairment.  The new guidance requires that an entity performs its annual or interim goodwill test by comparing the fair value of the reporting unit with its carrying amount.  An entity should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value.  The loss recognized should not exceed the total amount of goodwill allocated to that reporting unit.  The guidance is effective for the Company in fiscal year 2021, with early adoption permitted.  The standard was implemented in the first quarter of fiscal 2018.

In October 2016 the FASB issued new guidance regarding income taxes.  The new guidance will require the tax effects of intercompany transactions, other than sales of inventory, to be recognized currently, eliminating an exception under current Generally Accepted Accounting Principles (GAAP) in which the tax effects of intra-entity asset transfers are deferred until the transferred asset is sold to a third party or otherwise recovered through use.  The Company is evaluating the effect the updated standard will have on the Company’s consolidated financial statements and related disclosures.  The guidance will be effective for the company in fiscal year 2019, with early adoption permitted.

In August 2016 the FASB issued new guidance addressing how certain cash receipts and cash payments are presented and classified in the statement of cash flows.  The Company is evaluating the effect the updated standard will have on the Company’s consolidated financial statements and related disclosures.  The guidance will be effective for the Company in fiscal year 2019, with early adoption permitted.

In June 2016 the FASB issued a new standard on the measurement of credit losses, which will impact the Company’s measurement of trade receivables.  The new standard replaces the current incurred loss model with a forward-looking expected loss model that is likely to result in earlier recognition of losses.  The Company is evaluating the effect the updated standard will have on the Company’s consolidated financial statements and related disclosures.  The new standard is effective for the Company in 2021, with early adoption permitted, but not earlier than 2020.

In February 2016 the FASB issued a new lease accounting standard, which provides revised guidance on accounting for lease arrangements by both lessors and lessees.  The central requirement of the new standard is that lessees must recognize lease-related assets and liabilities for all leases with a term longer than 12 months.  The Company is evaluating the effect the standard will have on the Company’s consolidated financial statements and related disclosures.  The new standard is effective for the Company in fiscal year 2020, with early adoption permitted.

In July 2015, the FASB issued guidance which simplifies the subsequent measurement of inventory by requiring inventory to be measured at the lower of cost and net realizable value. Net realizable value is the estimated selling price of inventory in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation.  This new guidance was adopted in the first quarter of fiscal 2018, with no impact to the Company’s consolidated financial statements and related disclosures.

Revenue Recognition

In May 2014 the FASB issued a comprehensive new revenue recognition standard that effectively replaces all current guidance on the topic.  The guidance permits the use of either a retrospective or a cumulative effect transition method.

The Company has performed a review of the new guidance against the Company’s current accounting practices.  The Company has reviewed a representative sample of contracts and other agreements with customers and evaluated the provisions contained within these agreements compared with the amended guidance.

This amended guidance is expected to change the revenue recognition practices for a number of revenue streams across our businesses; the most significant will be for certain U.S. government contracts and certain other contracts that meet one or more of the mandatory criteria, which will move revenue recognition from a “point-in-time” basis to an “over-time” basis.  The on-going effect of recording revenue on an “over-time” basis is not expected to be materially different than under the historical guidance.

The amended guidance is also expected to change the recognition of certain development costs that are contractually guaranteed for reimbursement by our customers.  Contractually guaranteed reimbursements for development efforts are currently recognized as the development activities are performed.  Under the amended guidance, the contractually guaranteed reimbursement specific to the development effort will be deferred as a contract liability and recognized as revenue when future products are delivered to the customer in cases where the Company does not transfer all intellectual property rights related to the development effort to the customer or does not have an enforceable right to payment for performance completed to date.  The costs associated with development effort under an arrangement with contractually guaranteed reimbursement will also be deferred, up to the amount reimbursed, and recognized through cost of goods sold as products are delivered to the customer.  The on-going effect of deferring contractually guaranteed reimbursements and the related costs until products are delivered to the customer is not expected to be materially different than under the historical guidance.

The new standard also significantly enhances required disclosures regarding revenue and related assets and liabilities.  The Company is in the process of implementing changes to business processes, systems and internal controls required to adopt the new accounting standard.

The updated standard becomes effective for the Company in the first quarter of fiscal 2019, with early adoption permitted.  The Company expects to apply the standard using the cumulative effect transition basis, with a cumulative effect adjustment recognized at the beginning of fiscal year 2019.

XML

Earnings Per Share and Shareholders Equity (Tables)

3 Months Ended

Dec. 29, 2017

Earnings Per Share [Abstract]

Shares Used for Calculating Earnings Per Share

Shares used for calculating earnings per share are disclosed in the following table:

In Thousands	Three Months Ended
	December 29,		December 30,
	2017		2016
Shares used for basic earnings per share		29,903		29,547
Shares used for diluted earnings per share		29,903		29,831

Schedule of Changes in Issued and Outstanding Common Shares and Treasury Stock

Changes in issued and outstanding common shares are summarized as follows:

	Three Months Ended			Year Ended
	December 29,			September 29,
	2017			2017
Shares Issued:
Balance, beginning of year		33,117,473			32,564,252
Shares issued under share-based compensation plans		27,693			553,221
Balance, end of current period		33,145,166			33,117,473
Treasury Stock:
Balance, beginning of year		(3,135,927	)		(3,135,927	)
Shares purchased		(287,500	)		-
Balance, end of current period		(3,423,427	)		(3,135,927	)
Shares outstanding, end of period		29,721,739			29,981,546

Schedule of Components of Accumulated Other Comprehensive Income (Loss)

The components of Accumulated Other Comprehensive Income (Loss):

In Thousands	December 29,			September 29,
	2017			2017
Unrealized gain on derivative contracts	$	12,909		$	13,469
Tax effect		(3,782	)		(3,892	)
		9,127			9,577
Pension and post-retirement obligations		(80,940	)		(81,782	)
Tax effect		27,659			27,956
		(53,281	)		(53,826	)
Foreign currency translation adjustment		(216,267	)		(222,621	)
Accumulated other comprehensive income (loss)	$	(260,421	)	$	(266,870	)

XML

Retirement Benefits (Tables)

3 Months Ended

Dec. 29, 2017

Compensation And Retirement Disclosure [Abstract]

Schedule of Net Periodic Pension Cost

The Company’s pension plans principally include a U.S. pension plan maintained by Esterline and a non-U.S. plan maintained by CMC Electronics, Inc. (CMC).  The Company also sponsors a number of other non-U.S. defined benefit pension plans, primarily in Belgium, France and Germany.  Components of periodic pension cost consisted of the following:

In Thousands	Three Months Ended
	December 29,			December 30,
	2017			2016
Components of Net Periodic Cost
Service cost	$	3,374		$	3,357
Interest cost		4,106			3,721
Expected return on plan assets		(6,808	)		(6,265	)
Amortization of prior service cost		126			114
Amortization of actuarial (gain) loss		797			1,763
Net periodic cost (benefit)	$	1,595		$	2,690

XML

Fair Value Measurements (Tables)

3 Months Ended

Dec. 29, 2017

Fair Value Disclosures [Abstract]

Schedule of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis

The following table sets forth the Company’s financial assets and liabilities that were measured at fair value on a recurring basis by level within the fair value hierarchy at December 29, 2017, and September 29, 2017.

In Thousands	Level 2
	December 29,		September 29,
	2017		2017
Assets:
Derivative contracts designated as hedging instruments	$	13,273	$	13,932
Derivative contracts not designated as hedging instruments		893		284
Embedded derivatives		681		746
Liabilities:
Derivative contracts designated as hedging instruments	$	364	$	464
Derivative contracts not designated as hedging instruments		1,445		2,440
Embedded derivatives		1,792		2,239

In Thousands	Level 3
	December 29,		September 29,
	2017		2017
Assets:
Estimated value of assets held for sale	$	16,844	$	19,835
Liabilities:
Estimated value of liabilities held for sale	$	5,189	$	8,908

XML

Derivative Financial Instruments (Tables)

3 Months Ended

Dec. 29, 2017

Derivative Instruments And Hedging Activities Disclosure [Abstract]

Fair Value of Derivative Instruments In Consolidated Balance Sheet

Fair value of derivative instruments in the Consolidated Balance Sheet at December 29, 2017, and September 29, 2017, consisted of:

In Thousands		Fair Value
		December 29,		September 29,
	Classification	2017		2017
Foreign Currency Forward Exchange Contracts:
	Other current assets	$	11,708	$	11,433
	Other assets		2,458		2,783
	Accrued liabilities		1,653		2,506
	Other liabilities		156		398
Embedded Derivative Instruments:
	Other current assets	$	534	$	604
	Other assets		147		142
	Accrued liabilities		1,306		1,657
	Other liabilities		486		582

Effect of Derivative Instruments on Consolidated Statement of Operations and Comprehensive Income (Loss)

The effect of derivative instruments on the Consolidated Statement of Operations and Comprehensive Income (Loss) for the three-month periods ended December 29, 2017, and December 30, 2016, consisted of:

Fair Value Hedges and Embedded Derivatives

The Company recognized the following gains (losses) on contracts designated as fair value hedges and embedded derivatives:

In Thousands	Three Months Ended
Gain (Loss)	December 29,			December 30,
	2017			2016
Fair Value Hedges:
Recognized in cost of sales	$	(378	)	$	(933	)
Recognized in selling, general & administrative		(323	)		(768	)
Embedded derivatives:
Recognized in sales	$	345		$	253

Cash Flow Hedges

The Company recognized the following gains (losses) on contracts designated as cash flow hedges:

In Thousands	Three Months Ended
Gain (Loss)	December 29,			December 30,
	2017			2016
Foreign currency forward exchange contracts:
Recognized in AOCI (effective portion)	$	(2,493	)	$	(2,416	)
Reclassified from AOCI into sales		1,933			(4,425	)

Net Investment Hedges

The Company recognized the following gains (losses) on contracts designated as net investment hedges:

In Thousands	Three Months Ended
Gain (Loss)	December 29,			December 30,
	2017			2016
2023 Notes and Accrued Interest:
Recognized in AOCI	$	(6,297	)	$	23,913

XML

Income Taxes (Tables)

3 Months Ended

Dec. 29, 2017

Income Tax Disclosure [Abstract]

Summary of Income Tax Rate Before and After the Act

The following table summarizes the income tax rate for the first quarter of fiscal 2018 excluding and including the provisional taxes due to the Act.

In Thousands	Three Months Ended
	December 29, 2017
	Excluding			Including
Earnings from Continuing Operations Before Income Taxes	$	19,327		$	19,327
Income Tax Expense		5,573			5,573
Change in Tax Rate Due to the Act		(368	)		(368	)
Provisional Taxes Due to the Act		-			48,584
Total Income Tax Expense		5,205			53,789
Tax Rate		26.9	%		278.3	%

XML

Debt (Tables)

3 Months Ended

Dec. 29, 2017

Debt Disclosure [Abstract]

Long-Term Debt

Long-term debt at December 29, 2017 and September 29, 2017, consisted of the following:

In Thousands	December 29,			September 29,
	2017			2017
U.S. credit facility	$	70,000		$	50,000
U.S. Term Loan, due April 2020		221,875			225,000
3.625% Senior Notes, due April 2023		396,099			389,862
Government refundable advances		45,464			45,549
Obligation under capital leases		70,693			71,091
Debt issuance costs		(4,415	)		(4,654	)
		799,716			776,848
Less current maturities		17,429			17,424
Carrying amount of long-term debt	$	782,287		$	759,424

XML

Employee Stock Plans (Tables)

3 Months Ended

Dec. 29, 2017

Equity Incentive Plan

Share Based Compensation Arrangement By Share Based Payment Award [Line Items]

Fair Value of Option Granted using Black-Scholes Pricing Model

The fair value of each option granted by the Company was estimated using a Black-Scholes pricing model, which uses the assumptions noted in the following table.

	Three Months Ended
	December 29,	December 30,
	2017	2016
Volatility	34.32%	34.97 - 35.42%
Risk-free interest rate	2.15 - 2.47%	1.98 - 2.51%
Expected life (years)	5 - 9	5 - 9
Dividends	0	0

XML

Discontinued Operations (Tables)

3 Months Ended

Dec. 29, 2017

Discontinued Operations And Disposal Groups [Abstract]

Schedule of Discontinued Operations

The operating results of the discontinued operations for the three-month period ended December 29, 2017, consisted of the following:

In Thousands	Avionics &			Sensors &		Advanced
	Controls			Systems		Materials			Other		Total
Net Sales	$	-		$	-	$	-		$	-	$	-
Operating earnings (loss)		14			-		(283	)		-		(269	)
Tax expense (benefit)		23			-		(126	)		-		(103	)
Income (loss) from discontinued    operations	$	(9	)	$	-	$	(157	)	$	-	$	(166	)
Included in Operating Earnings (Loss):
Gain (loss) on net assets    held for sale	$	(51	)	$	-	$	140		$	-	$	89

The operating results of the discontinued operations for the three-month period ended December 30, 2016, consisted of the following:

In Thousands	Avionics &			Sensors &		Advanced
	Controls			Systems		Materials			Other			Total
Net Sales	$	2,696		$	-	$	-		$	-		$	2,696
Operating earnings (loss)		(871	)		895		(5,347	)		(604	)		(5,927	)
Tax expense (benefit)		(239	)		-		(141	)		(211	)		(591	)
Income (loss) from discontinued    operations	$	(632	)	$	895	$	(5,206	)	$	(393	)	$	(5,336	)
Included in Operating Earnings (Loss):
Gain (loss) on net assets    held for sale	$	(140	)	$	-	$	(4,588	)	$	-		$	(4,728	)

Assets and Liabilities Held for Sale within the Consolidated Balance Sheet at December 29, 2017, are comprised of the following:

In Thousands	Avionics &		Sensors &		Advanced
	Controls		Systems		Materials		Total
Other current assets	$	-	$	-	$	2,834	$	2,834
Current Assets of Businesses Held for Sale		-		-		2,834		2,834
Net property, plant and equipment		5,262		-		-		5,262
Other assets		-		-		8,748		8,748
Non-Current Assets of Businesses Held for Sale		5,262		-		8,748		14,010
Accounts payable		-		-		54		54
Accrued liabilities		-		-		2,063		2,063
Current Liabilities of Businesses Held for Sale		-		-		2,117		2,117
Deferred income tax liabilities		-		-		2,752		2,752
Other liabilities		-		-		320		320
Non-Current Liabilities of Businesses Held for Sale		-		-		3,072		3,072
Net Assets of Businesses Held for Sale	$	5,262	$	-	$	6,393	$	11,655

Assets and Liabilities Held for Sale within the Consolidated Balance Sheet at September 29, 2017, were comprised of the following:

In Thousands	Avionics &		Sensors &		Advanced
	Controls		Systems		Materials		Total
Other current assets	$	-	$	-	$	6,501	$	6,501
Current Assets of Businesses Held for Sale		-		-		6,501		6,501
Net property, plant and equipment		5,262		-		-		5,262
Other assets		-		-		8,072		8,072
Non-Current Assets of Businesses Held for Sale		5,262		-		8,072		13,334
Accounts payable		-		-		138		138
Accrued liabilities		-		-		7,046		7,046
Current Liabilities of Businesses Held for Sale		-		-		7,184		7,184
Deferred income tax liabilities		-		-		1,404		1,404
Other liabilities		-		-		320		320
Non-Current Liabilities of Businesses Held for Sale		-		-		1,724		1,724
Net Assets of Businesses Held for Sale	$	5,262	$	-	$	5,665	$	10,927

XML

Business Segment Information (Tables)

3 Months Ended

Dec. 29, 2017

Segment Reporting [Abstract]

Business Segment Information for Continuing Operations

Business segment information for continuing operations includes the segments of Avionics & Controls, Sensors & Systems and Advanced Materials.

In Thousands	Three Months Ended
	December 29,			December 30,
	2017			2016
Sales
Avionics & Controls	$	202,703		$	192,682
Sensors & Systems		175,468			167,756
Advanced Materials		103,874			97,978
	$	482,045		$	458,416
Earnings from Continuing Operations Before Income Taxes
Avionics & Controls	$	20,385		$	17,917
Sensors & Systems		11,713			18,143
Advanced Materials		14,583			9,880
Segment Earnings		46,681			45,940
Corporate expense		(20,048	)		(17,244	)
Interest income		298			96
Interest expense		(7,604	)		(7,888	)
	$	19,327		$	20,904

XML

Earnings Per Share and Shareholders Equity - Additional Information (Detail) - USD ($)	3 Months Ended			12 Months Ended	42 Months Ended
	Mar. 30, 2018	Dec. 29, 2017	Dec. 30, 2016	Sep. 29, 2017	Dec. 29, 2017	Mar. 31, 2015	Jun. 19, 2014
Earnings Per Share And Shareholders Equity [Line Items]
Anti-dilutive shares excluded from computation of earnings per share			809,875
Preferred stock shares authorized		25,000			25,000
Preferred stock, par value		$ 100			$ 100
Common stock, shares authorized		60,000,000		60,000,000	60,000,000
Common stock, par value		$ 0.20		$ 0.20	$ 0.20
Preferred stock shares outstanding		0		0	0
Approved and authorized amount under the stock repurchase program						$ 400,000,000	$ 200,000,000
Additional approved and authorized amount under the stock repurchase program						$ 200,000,000
Stock repurchased during period, shares		287,500	0	0	3,737,327
Average price paid per share of repurchased stock		$ 71.11
Aggregate value of repurchased stock		$ 20,400,000			$ 352,000,000
Stock repurchase program, remaining authorized amount available for repurchase in future			$ 48,000,000
Subsequent Event
Earnings Per Share And Shareholders Equity [Line Items]
Stock repurchased during period, shares	313,900
Average price paid per share of repurchased stock	$ 72.25
Aggregate value of repurchased stock	$ 23,000,000
Series B Preferred Stock
Earnings Per Share And Shareholders Equity [Line Items]
Preferred stock shares authorized		475,000			475,000
Preferred stock, par value		$ 1.00			$ 1.00
Preferred stock shares outstanding		0		0	0

XML

Shares Used for Calculating Earnings Per Share (Detail) - shares shares in Thousands	3 Months Ended
	Dec. 29, 2017	Dec. 30, 2016
Earnings Per Share [Abstract]
Shares used for basic earnings per share	29,903	29,547
Shares used for diluted earnings per share	29,903	29,831

XML

Schedule of Changes in Issued and Outstanding Common Shares and Treasury Stock (Detail) - shares	3 Months Ended		12 Months Ended	42 Months Ended
	Dec. 29, 2017	Dec. 30, 2016	Sep. 29, 2017	Dec. 29, 2017
Equity [Abstract]
Balance, beginning of year	33,117,473	32,564,252	32,564,252
Shares issued under share-based compensation plans	27,693		553,221
Balance, end of current period	33,145,166		33,117,473	33,145,166
Balance, beginning of year	(3,135,927)	(3,135,927)	(3,135,927)
Shares purchased	(287,500)	0	0	(3,737,327)
Balance, end of current period	(3,423,427)		(3,135,927)	(3,423,427)
Shares outstanding, end of period	29,721,739		29,981,546	29,721,739

XML

Schedule of Components of Accumulated Other Comprehensive Income (Loss) (Detail) - USD ($) $ in Thousands	Dec. 29, 2017	Sep. 29, 2017
Accumulated Other Comprehensive Income Loss Net Of Tax [Abstract]
Unrealized gain on derivative contracts	$ 12,909	$ 13,469
Tax effect	(3,782)	(3,892)
Unrealized gain on derivative contracts, Total	9,127	9,577
Pension and post-retirement obligations	(80,940)	(81,782)
Tax effect	27,659	27,956
Pension and post-retirement obligations, Total	(53,281)	(53,826)
Foreign currency translation adjustment	(216,267)	(222,621)
Accumulated other comprehensive income (loss)	$ (260,421)	$ (266,870)

XML

Schedule of Net Periodic Pension Cost (Detail) - Pension Plans, Defined Benefit - USD ($) $ in Thousands	3 Months Ended
	Dec. 29, 2017	Dec. 30, 2016
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 3,374	$ 3,357
Interest cost	4,106	3,721
Expected return on plan assets	(6,808)	(6,265)
Amortization of prior service cost	126	114
Amortization of actuarial (gain) loss	797	1,763
Net periodic cost (benefit)	$ 1,595	$ 2,690

XML

Schedule of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) - USD ($) $ in Thousands	Dec. 29, 2017	Sep. 29, 2017
Level 2
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Derivative contracts designated as hedging instruments, Assets	$ 13,273	$ 13,932
Derivative contracts not designated as hedging instruments, Assets	893	284
Embedded derivatives, Assets	681	746
Derivative contracts designated as hedging instruments, Liabilities	364	464
Derivative contracts not designated as hedging instruments, Liabilities	1,445	2,440
Embedded derivatives, Liabilities	1,792	2,239
Level 3
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Estimated value of assets held for sale	16,844	19,835
Estimated value of liabilities held for sale	$ 5,189	$ 8,908

XML

Derivative Financial Instruments - Additional Information (Detail) € in Millions, $ in Millions	1 Months Ended	3 Months Ended
	Apr. 30, 2015 EUR (€)	Dec. 29, 2017 USD ($)	Dec. 30, 2016 USD ($)	Sep. 29, 2017 USD ($)
Derivative [Line Items]
Gains (Losses) on foreign currency forward exchange contracts not designated as an accounting hedge		$ 1.5	$ (0.9)
Net Gain (Loss) expected to be reclassified into earnings over next 12 months		$ 10.9
Maturities of forecasted transactions using forward exchange contracts		24 months
3.625% Senior Notes, Due April 2023
Derivative [Line Items]
Debt instrument, interest rate	3.625%	3.625%		3.625%
Debt instruments maturity date	Apr. 30, 2023
Net Investment Hedges | 3.625% Senior Notes, Due April 2023
Derivative [Line Items]
Derivative notional amount | €	€ 330.0
Foreign Exchange Forward
Derivative [Line Items]
Derivative notional amount		$ 428.8		$ 406.9
Foreign Exchange Forward Contracts Related to Net Monetary Assets | Cash Flow Hedging
Derivative [Line Items]
Derivative notional amount		$ 69.2

XML

Fair Value of Derivative Instruments in Consolidated Balance Sheet (Detail) - USD ($) $ in Thousands	Dec. 29, 2017	Sep. 29, 2017
Foreign Exchange Forward | Other Current Assets
Derivatives Fair Value [Line Items]
Derivative Instruments, Assets	$ 11,708	$ 11,433
Foreign Exchange Forward | Other Assets
Derivatives Fair Value [Line Items]
Derivative Instruments, Assets	2,458	2,783
Foreign Exchange Forward | Other Liabilities
Derivatives Fair Value [Line Items]
Derivative Instruments, Liabilities	156	398
Foreign Exchange Forward | Accrued Liabilities
Derivatives Fair Value [Line Items]
Derivative Instruments, Liabilities	1,653	2,506
Embedded Derivative Financial Instruments | Other Current Assets
Derivatives Fair Value [Line Items]
Derivative Instruments, Assets	534	604
Embedded Derivative Financial Instruments | Other Assets
Derivatives Fair Value [Line Items]
Derivative Instruments, Assets	147	142
Embedded Derivative Financial Instruments | Other Liabilities
Derivatives Fair Value [Line Items]
Derivative Instruments, Liabilities	486	582
Embedded Derivative Financial Instruments | Accrued Liabilities
Derivatives Fair Value [Line Items]
Derivative Instruments, Liabilities	$ 1,306	$ 1,657

XML

Effect of Derivative Instruments on Consolidated Statement of Operations and Comprehensive Income (Loss) (Detail) - USD ($) $ in Thousands	3 Months Ended
	Dec. 29, 2017	Dec. 30, 2016
Fair Value Hedges | Cost of Sales
Derivative Instruments Gain Loss [Line Items]
Gains (losses) on contracts designated as fair value hedges and embedded derivatives	$ (378)	$ (933)
Fair Value Hedges | Selling, General & Administrative
Derivative Instruments Gain Loss [Line Items]
Gains (losses) on contracts designated as fair value hedges and embedded derivatives	(323)	(768)
Net Investment Hedges | 2023 Notes and Accrued Interest
Derivative Instruments Gain Loss [Line Items]
Gain (Loss) Recognized in AOCI	(6,297)	23,913
Embedded Derivatives | Sales
Derivative Instruments Gain Loss [Line Items]
Gains (losses) on contracts designated as fair value hedges and embedded derivatives	345	253
Foreign Exchange Forward | Cash Flow Hedging
Derivative Instruments Gain Loss [Line Items]
Gain (Loss) Recognized in AOCI (effective portion)	(2,493)	(2,416)
Gain (Loss) Reclassified from AOCI into sales	$ 1,933	$ (4,425)

XML

Insurance Recovery - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended
	Dec. 29, 2017	Mar. 31, 2017	Dec. 30, 2016	Sep. 30, 2016
Insurance [Abstract]
Insurance recovery received	$ 0	$ 5,200	$ 2,600	$ 5,000

XML

License Fee Income - Additional Information (Detail) - USD ($) $ in Thousands		3 Months Ended
	Dec. 22, 2017	Dec. 29, 2017	Dec. 30, 2016
Revenues [Abstract]
License income from third party	$ 3,000	$ 3,025	$ 0
Inventory and manufacturing equipment sold	$ 1,000
Royalty percentage on sale of licensed product		15.00%

XML

Income Taxes - Additional Information (Detail) - USD ($) $ in Thousands			3 Months Ended		9 Months Ended
	Dec. 22, 2017	Dec. 21, 2017	Dec. 29, 2017	Dec. 30, 2016	Sep. 28, 2018
Income Taxes [Line Items]
U.S. federal corporate tax rate	21.00%	35.00%	35.00%
Recognized provisional amount as component of income tax expense from continuing operations due to change in tax rate			$ 48,600
Remeasurement of deferred tax assets and liabilities based on rate at which expected to reverse in future			21.00%
Provisional amount recorded related to remeasurement of deferred tax balance			$ 6,600
Provisional amount for one-time transition tax liability resulting in increase in income tax expense due to foreign tax effects			$ 42,000
Blended U.S. tax rate			24.50%
Income tax benefit (expense)			$ (53,789)	$ 463
Unrecognized tax benefit reasonably possible to be recognized by the end of fiscal 2018			$ 1,400
Scenario, Forecast
Income Taxes [Line Items]
U.S. federal corporate tax rate					21.00%
New Guidance For Accounting Standard Update | Adjustments for New Accounting Principle, Early Adoption
Income Taxes [Line Items]
Income tax rate				(2.20%)
Discrete tax benefits related to valuation allowance release				$ 1,600
Income tax benefit (expense)				700
New Guidance For Accounting Standard Update | Adjustments for New Accounting Principle, Early Adoption | France
Income Taxes [Line Items]
Decrease in net deferred income tax liabilities				$ 3,800
New Guidance For Accounting Standard Update | Adjustments for New Accounting Principle, Early Adoption | Before Effect of Tax Cuts and Jobs Act
Income Taxes [Line Items]
Income tax rate			26.90%
New Guidance For Accounting Standard Update | Adjustments for New Accounting Principle, Early Adoption | After Effect of Tax Cuts and Jobs Act
Income Taxes [Line Items]
Income tax rate			278.30%

XML

Summary of Income Tax Rate Before and After the Act (Detail) - USD ($) $ in Thousands	3 Months Ended
	Dec. 29, 2017	Dec. 30, 2016
Income Taxes [Line Items]
Earnings from Continuing Operations Before Income Taxes	$ 19,327	$ 20,904
Change in Tax Rate Due to the Act	48,600
Total Income Tax Expense	53,789	(463)
New Guidance For Accounting Standard Update | Adjustments for New Accounting Principle, Early Adoption
Income Taxes [Line Items]
Total Income Tax Expense		$ (700)
Tax Rate		(2.20%)
New Guidance For Accounting Standard Update | Adjustments for New Accounting Principle, Early Adoption | Excluding Effect Of Tax Cuts And Jobs Act
Income Taxes [Line Items]
Earnings from Continuing Operations Before Income Taxes	19,327
Income Tax Expense	5,573
Change in Tax Rate Due to the Act	(368)
Provisional Taxes Due to the Act	0
Total Income Tax Expense	$ 5,205
Tax Rate	26.90%
New Guidance For Accounting Standard Update | Adjustments for New Accounting Principle, Early Adoption | Including Effect Of Tax Cuts And Jobs Act
Income Taxes [Line Items]
Earnings from Continuing Operations Before Income Taxes	$ 19,327
Income Tax Expense	5,573
Change in Tax Rate Due to the Act	(368)
Provisional Taxes Due to the Act	48,584
Total Income Tax Expense	$ 53,789
Tax Rate	278.30%

XML

Long-Term Debt (Detail) - USD ($) $ in Thousands	Dec. 29, 2017	Sep. 29, 2017
Debt Instrument [Line Items]
Credit facility	$ 70,000	$ 50,000
Government refundable advances	45,464	45,549
Obligation under capital leases	70,693	71,091
Debt issuance costs	(4,415)	(4,654)
Total long-term debt	799,716	776,848
Less current maturities	17,429	17,424
Carrying amount of long-term debt	782,287	759,424
U.S. Credit Facility
Debt Instrument [Line Items]
Credit facility	70,000	50,000
U.S. Term Loan, due April 2020
Debt Instrument [Line Items]
Term Loan	221,875	225,000
3.625% Senior Notes, due April 2023
Debt Instrument [Line Items]
Senior Notes	$ 396,099	$ 389,862

XML

Long-Term Debt (Parenthetical) (Detail)	3 Months Ended	12 Months Ended
	Dec. 29, 2017	Sep. 29, 2017	Apr. 30, 2015
3.625% Senior Notes, due April 2023
Debt Instrument [Line Items]
Long-term debt interest rate	3.625%	3.625%	3.625%
Debt instruments maturity period	2023-04	2023-04
U.S. Term Loan, due April 2020
Debt Instrument [Line Items]
Debt instruments maturity period	2020-04	2020-04

XML

Debt - Additional Information (Detail) € in Millions			1 Months Ended	3 Months Ended	12 Months Ended
	Aug. 03, 2015 USD ($)	Apr. 09, 2015 USD ($)	Apr. 30, 2015 USD ($)	Dec. 29, 2017 USD ($)	Sep. 29, 2017 USD ($)	Apr. 30, 2015 EUR (€)
Debt Instrument [Line Items]
Credit facilities				$ 70,000,000	$ 50,000,000
Imputed interest on advance				2.52%
Government refundable advances				$ 45,464,000	45,549,000
Present value of minimum lease payment				$ 68,600,000	$ 69,000,000
U.S. Term Loan, due April 2020
Debt Instrument [Line Items]
Loan amortization rate				1.25%
Debt instrument original principal balance maturity period				2020-03
Debt instruments maturity period				2020-04	2020-04
3.625% Senior Notes, Due April 2023
Debt Instrument [Line Items]
Debt instruments maturity period				2023-04	2023-04
Debt instrument, interest rate				3.625%	3.625%	3.625%
Fair market value of long-term debt and short-term borrowings				$ 406,100,000	$ 403,200,000
3.625% Senior Notes, Due April 2023 | TA Mfg Limited
Debt Instrument [Line Items]
Debt issuance costs			$ 5,900,000
Debt instrument, face amount | €						€ 330.0
Debt instrument, interest rate						3.625%
Net proceeds from issuance of debt			$ 350,800,000
3.625% Senior Notes, Due April 2023 | Debt Redemption Prior April 15, 2018 | TA Mfg Limited
Debt Instrument [Line Items]
Debt instrument redemption price percentage plus accrued interest			100.00%
Debt instrument redemption allowed percentage of principal amount redeemed			35.00%
3.625% Senior Notes, Due April 2023 | Debt Redemption After April 15, 2018 | TA Mfg Limited
Debt Instrument [Line Items]
Debt instrument redemption price percentage plus accrued interest			102.719%
3.625% Senior Notes, Due April 2023 | Debt Redemption After April 15, 2021 | TA Mfg Limited
Debt Instrument [Line Items]
Debt instrument redemption price percentage plus accrued interest			100.00%
London Interbank Offered Rate (LIBOR) | U.S. Term Loan, due April 2020
Debt Instrument [Line Items]
Interest rate, basis spread on variable rate				1.50%
Interest rate				2.85%
London Interbank Offered Rate (LIBOR) | Minimum | U.S. Term Loan, due April 2020
Debt Instrument [Line Items]
Interest rate, basis spread on variable rate	1.25%
London Interbank Offered Rate (LIBOR) | Maximum | U.S. Term Loan, due April 2020
Debt Instrument [Line Items]
Interest rate, basis spread on variable rate	2.00%
Delayed-Draw Term Loan Facility | U.S. Term Loan, due April 2020
Debt Instrument [Line Items]
Funds borrowed under the delayed-draw term Loan	$ 250,000,000
Secured Debt
Debt Instrument [Line Items]
Credit facility maturity date		Apr. 09, 2020
Debt issuance costs		$ 2,300,000
Credit facilities				$ 70,000,000
Secured Debt | London Interbank Offered Rate (LIBOR)
Debt Instrument [Line Items]
Interest rate, basis spread on variable rate				1.50%
Interest rate				2.82%
Secured Debt | London Interbank Offered Rate (LIBOR) | Minimum
Debt Instrument [Line Items]
Interest rate, basis spread on variable rate		1.25%
Secured Debt | London Interbank Offered Rate (LIBOR) | Maximum
Debt Instrument [Line Items]
Interest rate, basis spread on variable rate		2.00%
Secured Debt | Revolving Credit Facility
Debt Instrument [Line Items]
Credit facility maximum borrowing capacity		$ 500,000,000
Secured Debt | Delayed-Draw Term Loan Facility
Debt Instrument [Line Items]
Credit facility maximum borrowing capacity		$ 250,000,000

XML

Commitments and Contingencies - Additional Information (Detail) - USD ($) $ in Millions	Sep. 30, 2016	Mar. 05, 2014
Commitments And Contingencies Disclosure [Abstract]
Total penalty proposed by DTTC Office of Compliance		$ 20
Penalty suspended and eligible for offset credit		$ 10
Penalty suspended and approved for offset credit	$ 10

XML

Employee Stock Plans - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Dec. 29, 2017	Dec. 30, 2016
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based compensation	$ 3,998	$ 4,171
Shares issued under share-based compensation plans	27,693	237,547
Restricted Stock Units
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Granted	33,600	36,700
Weighted Average Grant Date Fair Value	$ 91.79	$ 76.70
Performance Share Plan Shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Granted	33,700	42,100
Performance period	3 years
Performance Share Plan Shares | Minimum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Percentage of the target number of shares paid out	0.00%
Performance Share Plan Shares | Maximum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Percentage of the target number of shares paid out	300.00%
Employee Share-save Scheme
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Discount rate of market value on purchase date	5.00%
The term of options, years	3 years
Number of options granted	0	0
Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of options granted	197,700	231,100
Weighted-average grant date fair value of options granted	$ 31.20	$ 32.55
Employee Stock Purchase Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Discount rate of market value on purchase date	5.00%

XML

Schedule of Fair Value of Option Granted using Black-Scholes Pricing Model (Detail) - Equity Incentive Plan - USD ($)	3 Months Ended
	Dec. 29, 2017	Dec. 30, 2016
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Volatility	34.32%
Volatility, minimum		34.97%
Volatility, maximum		35.42%
Risk-free interest rate, minimum	2.15%	1.98%
Risk-free interest rate, maximum	2.47%	2.51%
Dividends	$ 0	$ 0
Minimum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected life (years)	5 years	5 years
Maximum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected life (years)	9 years	9 years

XML

Discontinued Operations - Additional Information (Detail) $ in Thousands, £ in Millions					1 Months Ended		3 Months Ended
	Dec. 29, 2017 USD ($)	Dec. 29, 2017 GBP (£)	Mar. 28, 2017 USD ($)	May 04, 2016 GBP (£)	Dec. 29, 2017 USD ($)	Dec. 29, 2017 GBP (£)	Dec. 29, 2017 USD ($)	Dec. 30, 2016 USD ($)
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]
Loss from Discontinued Operations Attributable to Esterline, Net of Tax							$ (166)	$ (5,336)
Wallop
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]
Sale of discontinued operation | £				£ 2.5
Deferred consideration payments term				3 years
Deferred consideration payment date				May 03, 2019
Payments for earn out	$ 5,500	£ 4.1
Deferred consideration earned					$ 1,800	£ 1.3
Wallop | Maximum
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]
Deferred consideration payments | £				£ 9.0
Indemnity obligations losses for buyer | £				£ 5.0
Deferred consideration payable acceptable orders percentage				31.00%
Wallop | Minimum
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]
Deferred consideration payable acceptable orders percentage				26.50%
Small Manufacturing Business
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]
Sale of discontinued operation			$ 600
Discontinued operation, note receivable			2,400
Gain on sale of discontinued operation			$ 800
Discontinued operation, note receivable due date			Mar. 28, 2021
Discontinued operation ,note receivable interest rate			2.05%

XML

Discontinued Operations Income (Loss) Net of Tax (Detail) - USD ($) $ in Thousands	3 Months Ended
	Dec. 29, 2017	Dec. 30, 2016
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]
Net Sales	$ 0	$ 2,696
Operating earnings (loss)	(269)	(5,927)
Tax expense (benefit)	(103)	(591)
Income (loss) from discontinued operations	(166)	(5,336)
Included in Operating Earnings (Loss):
Gain (loss) on net assets held for sale	89	(4,728)
Avionics & Controls
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]
Net Sales	0	2,696
Operating earnings (loss)	14	(871)
Tax expense (benefit)	23	(239)
Income (loss) from discontinued operations	(9)	(632)
Included in Operating Earnings (Loss):
Gain (loss) on net assets held for sale	(51)	(140)
Sensors & Systems
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]
Net Sales	0	0
Operating earnings (loss)	0	895
Tax expense (benefit)	0	0
Income (loss) from discontinued operations	0	895
Included in Operating Earnings (Loss):
Gain (loss) on net assets held for sale	0	0
Advanced Materials
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]
Net Sales	0	0
Operating earnings (loss)	(283)	(5,347)
Tax expense (benefit)	(126)	(141)
Income (loss) from discontinued operations	(157)	(5,206)
Included in Operating Earnings (Loss):
Gain (loss) on net assets held for sale	140	(4,588)
Other
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]
Net Sales	0	0
Operating earnings (loss)	0	(604)
Tax expense (benefit)	0	(211)
Income (loss) from discontinued operations	0	(393)
Included in Operating Earnings (Loss):
Gain (loss) on net assets held for sale	$ 0	$ 0

XML

Discontinued Operations Assets and Liabilities Held for Sale (Detail) - USD ($) $ in Thousands	Dec. 29, 2017	Sep. 29, 2017
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]
Other current assets	$ 2,834	$ 6,501
Current Assets of Businesses Held for Sale	2,834	6,501
Net property, plant and equipment	5,262	5,262
Other assets	8,748	8,072
Non-Current Assets of Businesses Held for Sale	14,010	13,334
Accounts payable	54	138
Accrued liabilities	2,063	7,046
Current Liabilities of Businesses Held for Sale	2,117	7,184
Deferred income tax liabilities	2,752	1,404
Other liabilities	320	320
Non-Current Liabilities of Businesses Held for Sale	3,072	1,724
Net Assets of Businesses Held for Sale	11,655	10,927
Avionics & Controls
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]
Other current assets	0	0
Current Assets of Businesses Held for Sale	0	0
Net property, plant and equipment	5,262	5,262
Other assets	0	0
Non-Current Assets of Businesses Held for Sale	5,262	5,262
Accounts payable	0	0
Accrued liabilities	0	0
Current Liabilities of Businesses Held for Sale	0	0
Deferred income tax liabilities	0	0
Other liabilities	0	0
Non-Current Liabilities of Businesses Held for Sale	0	0
Net Assets of Businesses Held for Sale	5,262	5,262
Sensors & Systems
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]
Other current assets	0	0
Current Assets of Businesses Held for Sale	0	0
Net property, plant and equipment	0	0
Other assets	0	0
Non-Current Assets of Businesses Held for Sale	0	0
Accounts payable	0	0
Accrued liabilities	0	0
Current Liabilities of Businesses Held for Sale	0	0
Deferred income tax liabilities	0	0
Other liabilities	0	0
Non-Current Liabilities of Businesses Held for Sale	0	0
Net Assets of Businesses Held for Sale	0	0
Advanced Materials
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]
Other current assets	2,834	6,501
Current Assets of Businesses Held for Sale	2,834	6,501
Net property, plant and equipment	0	0
Other assets	8,748	8,072
Non-Current Assets of Businesses Held for Sale	8,748	8,072
Accounts payable	54	138
Accrued liabilities	2,063	7,046
Current Liabilities of Businesses Held for Sale	2,117	7,184
Deferred income tax liabilities	2,752	1,404
Other liabilities	320	320
Non-Current Liabilities of Businesses Held for Sale	3,072	1,724
Net Assets of Businesses Held for Sale	$ 6,393	$ 5,665

XML

Business Segment Information for Continuing Operations (Detail) - USD ($) $ in Thousands	3 Months Ended
	Dec. 29, 2017	Dec. 30, 2016
Segment Reporting Information [Line Items]
Sales	$ 482,045	$ 458,416
Interest income	298	96
Interest expense	(7,604)	(7,888)
Earnings from Continuing Operations Before Income Taxes	19,327	20,904
Avionics & Controls
Segment Reporting Information [Line Items]
Sales	202,703	192,682
Sensors & Systems
Segment Reporting Information [Line Items]
Sales	175,468	167,756
Advanced Materials
Segment Reporting Information [Line Items]
Sales	103,874	97,978
Operating Segments
Segment Reporting Information [Line Items]
Segment Earnings	46,681	45,940
Operating Segments | Avionics & Controls
Segment Reporting Information [Line Items]
Segment Earnings	20,385	17,917
Operating Segments | Sensors & Systems
Segment Reporting Information [Line Items]
Segment Earnings	11,713	18,143
Operating Segments | Advanced Materials
Segment Reporting Information [Line Items]
Segment Earnings	14,583	9,880
Corporate Non Segment
Segment Reporting Information [Line Items]
Corporate expense	$ (20,048)	$ (17,244)

XML

Subsequent Event - Additional Information (Detail) - Elastomer Business - Subsequent Event	Mar. 15, 2018 USD ($)
Subsequent Event [Line Items]
Sale of business	$ 50,000,000
Minimum
Subsequent Event [Line Items]
Loss on sale of business	5,000,000
Maximum
Subsequent Event [Line Items]
Loss on sale of business	$ 7,000,000